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The female menstrual cycle is inherently complex and there is great diversity in the hormonal 
profiles that maintain and govern the seemingly normal female reproductive cycle. Female sex 
hormones are linked to a breadth of physiological and psychological health mechanisms, yet 
timing, exposure, and flux of these hormones have been linked to both positive and negative 
health outcomes (Charkoudian, 2017; Dubey and Jackson, 2001; Henderson and Paganini-Hill, 
1994; Karapanou & Papadimitriou, 2010; McEwen, 2017; Parazzini, 1993; Seifert-Klauss, 2010; 
Solomon, 2002; Terry, 2005; Yoo, 2016). Physical activity can have a large influence on 
menstrual function (Ackerman et al., 2020; Burch, 2000; Loucks, 1998; Mena, 2019; Redman, 
2005; Reed, 2018; Sharma, 2013), and further exploration is needed to consider the balance 
between positive health benefits that come with exercise, and negative ones that may be 
associated with menstrual irregularities and infertility.  
 
The Health and Reproductive Survey (HeRS) was designed to investigate the impacts of physical 
activity and sport history participation on reproductive health from menarche to current 
(Ackerman, in press). The purpose of this study was to (1) investigate the reliability of (test-
retest) recall data regarding menstrual health (menarche to menopause), (2) explore correlations 
between activity level, BMI, and self-identified athlete type associated with age at menarche, (3) 
investigate activity profiles of women experiencing menstrual irregularities (prevalence of 
secondary amenorrhea in athletes vs. non), (4) investigate changes in physical activity level and 
menstrual cycle characteristics (i.e. frequency, duration, and intensity) and (5) explore the 
prevalence of women using birth control in various age ranges and by self-identified athlete 
type.  
 
Within this study, 144 respondents took part in a test-retest procedure of the HeRS at timepoint 
one (T1) and four months later (T4mo). The average age of respondents was 32.73 +/- 11.919. 
The majority of participants (76.4% of respondents) reported reaching menarche at a normal age 
 
 
(between the ages of 12-15). Average BMI at the age of menarche was 20.15 +/- 2.884 (n=97), 
with a minimum of 12.86 and a maximum of 36.56. At the time of menarche, 82.6% of 
respondents reported being physically active. The majority of respondents reported being 
physically active 5-10 hours per week (30.6%), with the next largest group reporting 11-15 hours 
of physical activity per week (20.1%). 
 
The reliability of recall for menarche related questions showed no distinct difference based on 
the current age of the respondent, but the lack of medical records to validate the accuracy of 
respondents’ answers suggests that while older age groups showed high recall reliability, there is 
no way of knowing if their answers are more or less accurate. There was no significant relation 
between hours of physical activity at menarche and age at menarche. Over 40% of women in 
each age range reported irregular cycles (> 12 cycles or <10 cycles per year), a much greater 
value than currently reported in the literature (1.8-5%) (Peterson et al., 1973; Singh, 1981). 
Physician diagnosis of disordered menstrual cycles was lower (18.1%-36.1%), but still much 
higher than values from existing research.  
 
A number of HeRS questions were dropped from recall reliability testing due to poor survey 
design causing skewed and unreliable respondent answers (i.e., height in high school, physical 
activity change). It is suggested that these questions, as well as altering overlapping age ranges 
(i.e., 13-18; 18-24) be adjusted before the next administration of the HeRS. Finally, since the 
objective of the HeRS is to track female reproductive health with a focus on the influence of 
physical activity and sport participation, questions should be added to each age section to better 
clarify the number of hours of physical activity performed per week as well as the intensity level 
of that activity (Beals, 2002; Dusek, 2001; Freedman, 2002; Lagowska & Kapczuk, 2016; 
Mountjoy, 2018). The length and repetitive nature of questions within each section of the HeRS 
should be acknowledged, and questions that provide less crucial information should be 
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The onset of menstruation represents a significant transition in the female lifespan—entrance 
into child-bearing age. The menstrual cycle in females is inherently complex and there is great 
diversity in the hormonal profiles that maintain and govern the seemingly normal female 
reproductive cycle. Female sex hormones are linked to an expanse of physiological and 
psychological health mechanisms, yet timing, exposure, and flux of these hormones have been 
linked to both positive and negative health outcomes. Physical activity can have a large influence 
on menstrual function, and further exploration is needed to weigh the balance between positive 
health associations that come with exercise, and negative ones that may be associated with 
menstrual irregularities and infertility.  
 
The female reproductive cycle refers to cyclical changes of the uterus in reaction to hormones 
produced by the hypothalamus, pituitary, and ovaries (Reed, 2018). While there are clinical 
guidelines as to what is considered a normal and healthy cycle, there is great inter-individual 
variation between women based on genetics, biology (body type, race), lifestyle (e.g., nutrition 
and exercise), and socioeconomic class (Karapanou and Papadimitrious, 2010). There is also a 
great amount of intra-individual variety within one’s lifetime that can be attributed to 
reproductive events such as pregnancy, lactation, and menopause, or disorders such as secondary 
amenorrhea or polycystic ovary syndrome (Ackerman et al., 2020).  
 
Female sex hormones are significant for growth and development during adolescence and for 
fertility during child-bearing years, but these hormones are also vital for general health across the 
lifespan. Sex hormones play a key role in the regulation of bone health, body temperature, 
cholesterol, and many organ systems (Charkoudian, 2017; Seifert-Klauss, 2010). Thus, 
deficiencies in these hormones impacts overall physical health and wellness, albeit the most 
obvious are linked to reproductive health. Early exposure to these hormones, such as observed in 
early menarche, has been linked to negative health consequences later in life, such as higher 




even after controlling for BMI, physical activity, smoking, alcohol, educational level, and more 
(Karapanou & Papadimitriou, 2010; Yoo, 2016).  
 
Energy expenditure has proven to play a significant role in menstrual cycle irregularities that are 
indicative of defects in hormone production (Reed, 2018). Both high energy availability (i.e., 
overweight and obesity) and low energy availability (i.e., eating disorders or excessive physical 
activity) have been linked to menstrual disturbances, infertility, and anovulation (Loucks, 1998; 
Mena, 2019; Redman, 2005; Sharma, 2013). Early life energy availability significantly impacts 
the age of menarche, with higher subcutaneous fat levels and BMI at prepubertal ages (5-9 years) 
associated with early menarche (<11 years) (Freedman, 2002), while high levels of physical 
activity has proven to significantly delay menarche (Dusek, 2001).  
 
Importantly, as the rate of obesity and overweight increases, concomitant with increasing 
numbers of exercising women and rising female sport participation, studying menstrual health is 
crucial (Mena, 2019; Warren, 2000). The long-term health consequences of menstrual 
irregularities must be clearly identified in order to establish guidelines for physical activity 
recommendations that optimize the health of females (Warren, 2000). Female athletes must be 
provided education related to training around the menstrual cycle for optimized adaptation and 
performance, while weighing the possible long-term health consequences (Birch, 2000; Warren, 
2000).  
 
Currently, there are very few in-depth surveys that record the life histories of reproductive health 
of a broad general female population. The Health and Reproductive Survey (HeRS) is a newly 
developed tool designed to collect reproductive histories across a large sample of females with 
the express goal of addressing the connectivity between physical activity and menstrual health 
across the lifespan.  
 
The purpose of this thesis study will be to (1) investigate the reliability of (test-retest) recall data 
regarding menstrual health (menarche to menopause) questions of the Health and Reproductive 
Survey (HeRS), (2) explore any correlations between activity level, BMI, and self-identified 




experiencing menstrual irregularities (prevalence of secondary amenorrhea in athletes vs. non), 
(4) investigate how changes in physical activity level may influence menstrual characteristics 
(i.e. frequency, duration, and intensity) of the menstrual cycle, (5) explore the prevalence of 
women using birth control at various age ranges and based on self-identified athlete type. The 
following hypothesis are based on previous research: 
 
Hypothesis 1: HeRS 4-month test-retest recall reliability will be acceptable for most survey 
questions.  
 
Hypothesis 2: HeRS 4-month test-retest recall reliability of the menarche section (part 1) will be 
high in younger females but lower in older females. 
 
Hypothesis 3: Females that reported higher activity levels at the age of menarche will also report 
older ages of menarche.  
 
Hypothesis 4: Females that self-identified as competitive athletes with higher activity levels will 
report fewer number of menstrual cycles per year than those that reported lower activity levels. 
 
Hypothesis 5: A decrease in physical activity level will be correlated to an increase in frequency, 
duration, and intensity of menstrual cycle, and vice versa.  
 













This literature review will discuss the normal menstrual cycle and female sex hormones, the role 
of physical activity in menstrual irregularities, methods for testing recall reliability, the Health 
and Reproductive Survey (HeRS), and limitations to the self-reported method of the HeRS.  
 
2.1 The Menstrual Cycle and Female Sex Hormones 
 
2.1.1 The Menstrual Cycle  
The female reproductive cycle refers to cyclical changes of the uterus in reaction to hormones 
produced by the hypothalamus, pituitary, and ovaries (Reed, 2018). Gonadotropin releasing 
hormone (GnRH), the hypothalamic releasing factor, causes release of follicle stimulating 
hormone (FSH)—initiating growth of a dominant follicle in the ovary (Birch, 2000; Reed, 2018). 
FSH and luteinizing hormone (LH) prime the ovary to secrete estradiol, peaking about 24 hours 
before ovulation (Birch, 2000; Reed, 2018).  The spike in estradiol causes a feedforward 
mechanism that releases more LH from the hypothalamic-pituitary axis (HPA) (Birch, 2000; 
Reed, 2018). Ovulation occurs at the peak surge of LH. The remaining cells of the follicle will 
continue to produce estradiol and progesterone, and these act via negative feedback on the axis to 
stop the release of FSH and LH (Birch, 2000; Reed, 2018). An illustration of a normative 







Figure 1: Hormonal, Ovarian, Endometrial, and Basal Body Temperature Changes and Relations 
Throughout the Normal Menstrual Cycle (Carr, 1998).  
 
 
2.1.2 The Roles of Female Sex Hormones  
Reproductive hormones play a key physiological role in growth and development through 
adolescence, fertility in adulthood, and the maintenance of various organ systems (Ackerman, in 




ovulation both contribute to establishing peak bone mass density in young girls (Seifert-Klauss, 
2010). Both hormones continue to collaborate in the remodeling of bone throughout adulthood, 
estradiol contributing to the resorption of bone tissue, and progesterone to the formation of new 
bone (Seifert-Klauss, 2010).  
 
Estrogen and progesterone also play a role in thermoregulation, both centrally and peripherally. 
Estradiol’s vasodilatory affects promote heat dissipation at the skin and lowers blood pressure in 
females (Charkoudian, 2017). Specifically, this response is accomplished by augmenting β-
adrenergic receptor mediated vasodilation and offsetting α-adrenergic vasoconstriction 
(Charkoudian, 2017), resulting in an overall weak relation between muscle sympathetic activity 
and blood pressure. On the contrary, progesterone promotes heat conservation and higher body 
temperatures (Charkoudian, 2017).  
 
Studies investigating the sex difference in the brain have highlighted the role of estrogen on 
extrahypothalamic brain function. Estradiol impacts learning and memory, excitability, 
neuroprotection, addiction, cardiovascular regulation, pain sensitivity, and fine motor skills, 
coordination, and reaction time (McEwen, 2017). Estradiol also protects neurons from 
excitotoxic damage during seizures, stroke, and Alzheimer’s disease (Henderson and Paganini-
Hill, 1994; McCullough et al., 2003). 
 
Ovarian hormones have also shown involvement in cholesterol production, immune response, 
and protection of the renal and cardiovascular systems (Dubey and Jackson, 2001; Khan and 
Ansar Ahmed, 2015).  
 
Proven to be significant across a spectrum of general health development, regulation, and 
maintenance, deficiencies in female sex hormones likely impact overall health and wellness. 
Insufficient exposure (measured by menstrual irregularity) is linked to increased risk for type 2 
diabetes, coronary heart disease and osteoporosis (Solomon, 2001; Solomon, 2002). Yet, less 
exposure—categorized by longer or irregular cycles, has also been shown to have a protective 
effect resulting in reduced risk of breast and ovarian cancer (Parazzini, 1993; Terry, 2005). 




menarche) has been linked to negative health outcomes later in life including higher incidence of 
obesity, diabetes, cardiovascular disease, and cancer (Karapanou & Papadimitriou, 2010; Yoo, 
2016). Even after controlling for age, physical activity, smoking, alcohol, educational level, 
occupational social class, oral contraceptive use, hormone replacement therapy, BMI and waist 
circumference, women who experienced early menarche were at higher risk for hypertension, 
cardiovascular disease, coronary heart disease, all-cause mortality, cardiovascular disease 
mortality, and cancer mortality (Lakshman 2009).  
 
However, late menarche is associated with poorer bone health. Studies investigating post-
menopausal women have found those who reached menarche later have lower mineral density at 
the forearm, spine, and proximal femur, putting them at greater risk for fractures (Fox, 1993). 
Women who experienced early menarche have been found to have slightly higher bone mineral 
density of the lumbar spine and femoral neck into old age (controlled for BMI) even when 
compared to women who received hormone replacement therapy (Gerdhem, 2004). 
 
Unfortunately, categorization of females into ‘early’ or ‘late’ menarche as a proxy for duration of 
hormone exposure when investigating the effect of sex-steroid hormones on long-term health 
outcomes in women is far too simplistic. This method fails to consider many other factors 
implicit in hormone exposure over the lifespan since; 1) great variability occurs in the timeframe 
it takes for a girl to establish a regular cycle, 2) life events (such as pregnancy) and secondary 
amenorrhea alter a woman’s exposure to reproductive hormones, 3) anovulatory cycles or luteal 
phase defects reduce total hormone output compared to normal and perhaps most importantly, 4) 
use of hormonal contraceptives (oral or other) and infertility treatments (i.e. extensive exposure 
to hormones and manipulation of cycles) over the lifespan is not considered. Even cycle length, 
which has been suggested as a relevant indicator of estradiol exposure, has shown that women 
with short cycles will experience less hormonal exposure per-cycle, but cumulative exposure 
over time is greater (Mumford et al., 2012).  
 
The eumenorrheic ‘normal’ cycle lasts on average 29 days, but clinical guidelines state anything 
between 25-30 days as normal (Bull, 2019; Reed, 2018). The average age of menarche is 12 




significant inter-individual variation of menses events and cycling between females, as well as 
intra-individual variation across one’s lifetime. Inter-individual variation has been studied 
largely in the context of age of menarche, but also menstrual regularity. Associations with 
menstrual regularity have been made with many factors including genetics (e.g., the Kiss 1 
gene), biology (e.g., race, BMI), lifestyle (e.g., physical activity and nutrition), socioeconomical 
(e.g., low socioeconomic status), and even geographical (e.g., country, climate) (Karapanou & 
Papadimitriou, 2010). Intra-individual variation across one’s lifetime can involve early menarche 
(before the age of 12) or late menarche (primary amenorrhea; after the age of 15), 
oligomenorrhea (cycles lasting longer than 35 days), anovulation (a cycle without ovulation), 
dysmenorrheal (pain with menstruation), heavy menstrual bleeding (more than 80mL lost; (Reed, 
2018)), and luteal phase defects (smaller window of time between ovulation and period). In 
addition, other life events can alter the normal cycle, including pregnancy (increases in estrogen 
and progesterone accompany amenorrhea), and lactation amenorrhea (increased prolactin 
decreases release of gonadotropin releasing hormone, thus reproductive hormones) (Ackerman et 
al, 2020). Lastly, disorders such as polycystic ovary syndrome (PCOS), endometriosis, 
hyperprolactinemia, Asherman’s syndrome, and various medications have the ability to impact 
normal menstrual rhythms. The issue of PCOS is increasingly important, since the worldwide 
prevalence has steadily increased and the definition and etiology are poorly described 
(Barthelmess & Naz 2014). These disturbances indicate that defects somewhere along the 
hypothalamic-pituitary-ovarian-uterine axis (Reed, 2018) are responsible for dysfunction.  
 
2.2 Physical Activity and Menstrual function 
Looking closer at the association between physical activity and the female sex hormones (i.e., 
estrogen and progesterone), it becomes evident that the relationship is bidirectional (Ackerman et 
al. 2020). Not only do estrogen and progesterone impact the growth, development, and 
regulation of imperative organ systems required to perform and succeed in physical activity, but 
further associations have been found between menstrual phase and physical performance, as well 
as physical activity effects on estrogen and progesterone availability (Burch, 2000). These 
findings suggest a series of highly integrated feedback/feedforward loops that systematically 





Investigations addressing the impact of menstrual cycle phase on physical performance measures 
have produced significant variability in findings—at least partly due to inconsistent utilization of 
standardized methodology, incomplete or poor reporting of methods, or some combination of 
these issues. In addition, failure to clarify definitions and distinctions between physical activity, 
performance and exercise further obfuscate the literature. Herein, this document defines physical 
activity as any bodily movement that requires energy expenditure (Caspersen et al, 1985). 
Exercise is a subcategory of physical activity that is planned, structured, repetitive and 
purposeful and is intended to improve or maintain fitness (Caspersen et al, 1985). Fitness is the 
state of being fit (Caspersen et al, 1985) for the ability to perform sports, occupations, or daily 
activities, while athletic performance describes the efforts made by an athlete to attain specific 
performance objectives over a period of time (Ackerman et al, 2020). Since the HeRS is intended 
to serve the broad population of women, and assess menstrual function across the entire life 
course, the questionnaire investigates physical activity participation as well as competitive 
athletic or sport participation.  
 
2.2.1 Performance and the Menstrual Cycle 
A few older studies report variations in performance based on menstrual cycle phase, including 
decreases in performance during menses of 50 m swimmers (Bale and Nelson, 1985), increased 
handgrip strength during menses with no effect on standing broad jump (Davies et al. 1991) and 
no difference in handgrip strength across menstrual phases (Higgs and Robertson 1981). Later 
studies implied a positive relationship between estrogen peak in the late follicular phase and 
strength (maximum voluntary force) (Phillips et al., 1996), however the determination of phase 
in these studies is questionable. De Jonge (2001) found no effect of menstrual phase on 
quadricep and hamstring strength and fatiguability or handgrip strength.  
 
At rest, estrogen levels have significant effects on metabolism through various mechanisms 
(Bunt, 1990). And, since acute bouts of exercise increase concentrations of estrogen and 
progesterone due to changes in hepatic clearance rates or increased secretion (Bonen et al., 
1991), it seems likely that increased estrogen concentrations will have some metabolic effect 
during exercise. Estrogen has significant effects on metabolism that imply a glycogen-sparing 




of estrogen have; 1) correlated with higher insulin levels and decreased glucagon levels, resulting 
in an inhibition of gluconeogenesis and glycogenolysis, 2) increased synthesis of triglycerides 
and high-density lipoproteins, 3) increased lipolysis in muscle and adipose and 4) increased 
production of catecholamines, causing increases in growth hormone and cortisol throughout the 
system. Both growth hormone and cortisol have a contra-insulin effect, leading to a decrease in 
peripheral glucose up-take and utilization (Bunt, 1990). Thus, it would seem that when estrogen 
concentrations are highest during the luteal phase of the menstrual cycle, glycogen-sparing 
would enhance performance in the context of exercise to exhaustion (Bunt, 1990). A study of six 
eumenorrheic females reported exercise time to exhaustion was greater during the midluteal 
phase, as well as glycogen repletion following a depletion exercise bout, while glycogen 
utilization during the time to exhaustion exercise did not differ (Nicklas et al. 1989). This implies 
an increased concentration of free fatty acids, which enhance performance (Birch, 2000). 
However, Gordon (2018) found no significant effect of menstrual cycle phase on maximal 
oxygen uptake (VO2 max). While results vary, it remains unclear whether the fluctuations of 
female sex hormone concentrations throughout the menstrual cycle significantly influence 
athletic performance.  
 
2.2.2 The Influence of Physical Activity on Energy Balance and the Menstrual Cycle 
More evident is the effect of physical activity on female hormone flux, specifically the impact of 
energy expenditure and overall energy balance, on menstrual dysfunction. Energy expenditure 
has proven to be significant in the role of menstrual cycle irregularities indicative of a defect in 
hormone production (Reed, 2018). Energy availability (EA), both high (i.e., overweight and 
obesity) and low (i.e., eating disorders or physical activity), have been linked to menstrual 
disturbances, infertility, and anovulation (Loucks, 1998; Mena, 2019; Redman, 2005; Sharma, 
2013). High energy availability through a greater caloric consumption than energy expenditure 
(physical activity) is widely known to associate with menstrual irregularities (Mena, 2019; 
Talmor, 2015). Obesity is a major etiology for menstrual irregularities and infertility, driven by 
an increase in free androgens and concurrent insulin resistance, causing disruption in the 
hypothalamic-pituitary-ovarian axis, oocyte quality, and endometrial receptivity (Sharma, 2013; 
Talmor, 2015). Increased adiposity causes an increase in peripheral aromatization of androgens 




(Talmor, 2015). This is intensified by hyperinsulinemia which decreases SHBG further and 
increases androgen production by the ovaries (Talmor, 2015). The result is an over-secretion of 
LH, and increased estrogen to androgen ratio, which leads to folliculogenesis and anovulation 
(Talmor, 2015).  
 
Decreasing the high energy availability through weight loss from physical activity treatment or 
surgical approaches restores menstrual regularity, signifying energy availability has a key 
connection to the HPO axis. Physical activity has proven as effective as fertility treatment or 
treatment for PCOS in improving pregnancy rates, conception rates, ovulation rates, and 
menstrual regularity (Mena, 2019). Bariatric surgery also restores regular menstruation in >70% 
of anovulatory obese women (Teitelman, 2006).  
 
Low energy availability, defined as the dietary energy left over after exercise that is available for 
physiological functions such as growth, muscle recovery, and homeostasis (Mountjoy, 2018), is 
just as tied to menstrual irregularities and infertility. Here, female athletes often experience 
delayed menarche and increased prevalence of secondary amenorrhea (Dusek, 2001). High-
intensity training before menarche has been shown to postpone its onset (Dusek, 2001). In a 
study of 425 collegiate athlete across 15 sports at seven US universities, Beals (2002) found 
7.4% had experienced primary amenorrhea (had not menstruated by age 16), and this prevalence 
increased to 22.2% within the aesthetic sports (i.e. cheerleading, diving, and gymnastics), while 
the prevalence of primary amenorrhea in the general population is <1% (Chumlea, 2003). While 
genetics have proven to relate mothers and daughters to age at menarche, this correlation is less 
pronounced in the athlete (Warren, 2000). Energy availability in younger years shows 
significance regarding the age of menarche, with higher subcutaneous fat levels and BMI at 
prepubertal ages (5-9 years) associated with early menarche (<11 years) (Freedman, 2002) and 
low energy availability associated with later menarche (Lagowska & Kapczuk, 2016).  
 
Oligomenorrhea, luteal phase defects, anovulation, and amenorrhea in athletes are also very 
common (Redman, 2005). In a study of 72 female athletes, the overall prevalence of secondary 
amenorrhea across multiple sports was three times higher in athletes than in the control group 




menstrual irregularities in athletes have been as high as 78% (61% oligomenorrheic and 17% 
amenorrhoeic) in rhythmic gymnasts ~1 year after menarche (Klentrou, 2003), although these 
findings should be viewed with caution given the proximity of the assessment to menarche. In a 
study of 52 endurance athletes (1500 m to marathon), Burrows (2003) found 23% were 
oligo/amenorrhoeic (only one participant was amenorrhoeic). In another study (Rosetta, 1998) of 
36 endurance runners, there was a 40% incidence of long and short cycles; the amenorrhoeic and 
oligomenorrheic runners logged more miles than the eumenorrheic athletes, and expressed lower 
body weights, younger ages, and significantly lower BMIs. The prevalence of oligomenorrhea or 
secondary amenorrhea of the general population of college students is around 10.6%, with 
secondary amenorrhea accounting for 2-5% (Singh, 1981). Table 1 shows prevalence vales for 
oligo- and amenorrhea in different athletic populations.  
 
 
Table 1. Surveys of the Prevalence of Amenorrhea and Oligomenorrhea in Different Athletic 
Disciplines. 
Activity Study n Percentage with irregularities 
General population:  





 Singh (1981) 900 5.0 
 
Weight bearing Sports: 




      Running 
 
 
Non-weight bearing sports: 
     Cycling 
     Swimming 
 
 
Abraham et al (1982) 
Brooks-Gunn et al (1987) 
Feicht et al (1978) 
Glass et al (1987) 
Shangold and Levine 
(1982) 
Sanborn et al (1982) 
 
 
Sanborn et al (1982) 
























Reproduced with permission of Constantantini NW & Warren MP 
 
 
The pathophysiology of the amenorrhoeic athlete is complex, involving prepubertal training, 
training load and intensity, regulated diets, and psychological stress (Redman, 2005; Warren, 




adaptations that lead to menstrual dysfunction are not fully elucidated (Warren, 2000). Early 
theories suggested a threshold of body fat, 22%, was necessary to produce a regular menstrual 
cycle (Warren, 2000). This was suggested since leptin, which is secreted by adipocytes and 
shown to be directly proportional to body fat mass, influences the GnRH pulse generator 
whereby abnormal levels may impair regular menstrual cycle generation (Kopp, 1997). 
However, more fine-grained investigations have shown that many athletes above this 22% body 
fat threshold still show menstrual cycle related irregularities, and normal cycles have been seen 
in athletes with body fat percentages below 17% (Loucks, 1985).  
 
Another theory established from animal studies implied physical activity activates the 
hypothalamic-pituitary-adrenal axis, causing a stress-response release of corticotrophin releasing 
factor (CRF) that suppresses the GnRH pulse generator (Warren, 2000). This would coincide 
with other stress-response hormone increases documented in amenorrheic athletes such as 
cortisol rhythms and adrenocorticotropic hormone (ACTH) (Warren, 2000).  
 
The most established theory lies in low energy availability causing a decrease in gonadotropin-
releasing hormone (GnRH) pulses from the hypothalamus, causing a decrease in pulsatile 
secretion of LH and FSH, turning off stimulation of the ovaries, and resultant decreases in 
estradiol and progesterone (Mountjoy, 2018; Redman, 2005; Warren, 2000). This connection 
between energy availability and amenorrhea is far more common in sports encouraged to have a 
low body weight (i.e. gymnastics, endurance running, dancing) (Dusek, 2001). In a meta-analysis 
of 28 studies, Redman (2005) found exercise had no disruptive effect on LH pulsatility beyond 
the impact on energy availability, which could be prevented with supplementation to the diet 
equal to exercise energy expenditure.  
 
Low energy availability and carbohydrate intake has been linked to higher testosterone levels in 
female athletes and ballerinas, suggesting a potential protective mechanism of testosterone 
against weight loss by building lean tissue mass (Miller et al., 2016), and indicating another 
potential mechanism of disruption of the HPO axis (Lagowska & Kapczuk, 2016). These 
athletes, however classified as experiencing hyperandrogenism, did not present hirsutism, acne, 




profile signified by hyperandrogenism shows higher androgen levels as well as elevated LH, 
increased LH:FSH ratio, and regular estrogen levels (Warren, 2000). While Lagoska & Kapczuk 
found this hyperandrogenism within the most severe low energy availability and menstrual 
dysfunction athletes, Sanborn (1982) indicates this profile was associated to sports where low 
body weight is not required (such as swimming), in which irregular/longer cycles (not complete 
amenorrhea) are more common. 
 
Concern over menstrual dysfunction in athletes arises with short term bone deficiencies, and 
long-term infertility. Athletes with shortened luteal phases, oligomenorrhoea, and anovulation 
often experience infertility (Redman, 2005), but this may be reversible with a halt in exercise and 
weight gain (Warren, 2000). Greater immediate concern involves amenorrhoeic athletes’ reduced 
bone mineral density (Otis, 1997) and increased frequency of stress fractures (Bennell, 1997). 
Originally believed to be due to chronic hypoestrogenism failing to inhibit the resorption of 
bone, bone densities of amenorrhoeic athletes are not restored with hormone replacement 
(Cummings, 1996) or oral contraceptive therapy (Rickenlund, 2004). Instead, these impairments 
in bone density may be due to other metabolic hormones reduced in amenorrhoeic athletes such 
as insulin, or insulin-like growth factor I (IGF-I) (Zanker, 1998).  
 
2.2.3 Female Athlete Triad (FAT) and Relative Energy Deficiency in Sport (RED-S) 
Research related to the influence of energy availability on hormone pulsatility in athletes has 
increased in recent years within two separate camps of research; the first called the Female 
Athlete Triad (FAT) and the other Relative Energy Deficiency in Sport (RED-S). FAT—specific 
to female athletes, established the connection between the causality of low energy availability 
leading to the distinct symptoms of menstrual irregularity, with the key morbidity outcome being 
low bone mineral density (Stand, 2007). RED-S has expanded on this platform, inclusive of male 
athletes, but also highlighting the broader long-term impacts of chronic energy deficiency on 
metabolic rate, bone health, immunity, protein synthesis, cardiovascular health, and menstrual 
function (Ackerman, 2020).  
 
Diagnostic factors of RED-S are broad and include; chronic dietary restriction and/or extreme 




training inconsistencies, prolonged fatigue, decreased libido, oligo-amenorrhoea (missing three 
or more menstrual cycles in 6 months), two or more career bone stress injuries and low bone 
mineral density for age (Ackerman, 2020, p. ). Athletes categorized as having low EA have 
increased health risks of menstrual dysfunction, poor bone health, metabolic issues, 
haematological detriments, psychological disorders, cardiovascular impairments, and 
gastrointestinal dysfunction (Ackerman, 2019). Performance decrements of low EA extend 
beyond limiting training adaptations and include impaired judgement, decreased coordination, 
decreased concentration, irritability, depression, and decreased endurance performance 
(Ackerman, 2019), as well as decreased testosterone, which is particularly significant for male 
athletes (Mountjoy, 2018).  
 
Ultimately, low energy availability described by exercise cost outweighing dietary energy 
remaining for normal physiological functions has been found to decrease training adaptation and 
increase risk of short and long-term health consequences. While menstrual irregularities are a 
key pillar within the FAT ideology, they remain significant indicators of low energy availability 
within the RED-S construct.  
 
As rates of obesity and overweight individuals increase, as well as the number of exercising 
women and female sport participation, studying menstrual health is crucial (Mena, 2019; 
Warren, 2000). The long-term health consequences of menstrual irregularities (and low EA) 
must be clearly identified in order to establish guidelines for physical activity recommendations 
for optimal health (Warren, 2000). Female athletes must be further educated on how to train 
around their menstrual cycle for optimized adaptation and performance, while weighing the 
possible health consequences long term (Ackerman, 2020; Birch, 2000; Warren, 2000).  
 
2.2.4 Usage of Oral Contraceptives in the Athletic Population 
There is no literature to our knowledge as to why athletes may be taking oral contraceptives. 
Many amenorrhoeic athletes are prescribed oral contraceptives as hormone therapy by physicians 
aligned with the common misconception that a supplementation of estrogen and progesterone 
will prevent bone mineral loss and reduce risk of bone injury. While Rickenlund (2004) and 




the practice is still quite common. We also predict female athletes likely to use oral 
contraceptives to manipulate their menstrual cycle either to assuage symptoms of dysmenorrhea 
or around times of competition due to beliefs that it hinders performance.  
 
While we may not know the underlying reasons as to why athletes are taking oral contraceptives, 
there are a few studies that provide figures of prevalence within athletic populations. Beals 
(2002) found that oral contraceptive use was reported in 26.7% of the 425 collegiate athletes 
surveyed. Agel (2006) found 32.5% of the 3,150 NCAA college athletes surveyed were taking 
some form of hormonal therapy. Paulus (2000) observed within the general adolescent 
population aged 12-17 (not specifically athletes), that 14% of the 784 Belgian students surveyed 
were taking oral contraceptives, two-thirds of which were low-dose pills of gestodene or 
desogestrel.  
 
Wojtys et al (1998) found that 20 of the 28 (71.4%) female recreational or competitive athletes 
(age 23 +/- 11 years; with previous ACL injuries) surveyed believed that their individual athletic 
performance was hindered during their menstrual cycle. This correlated to reported experiences 
of premenstrual symptoms. This was inversely related to oral contraceptive use, which was 
reported by 5 of the 28 (17.9%), who reported to have little or no premenstrual syndromes and 
their menstrual cycle having no impact on athletic performance. This supports what our 
hypothesis that many female athletes (especially more competitive ones) are likely to report 
using oral contraceptives to manipulate their menstrual cycle due to athletic participation.   
 
2.3 Methods for Testing Recall Reliability 
 
The gold standard method for validity of recall data in medical environments involves comparing 
interview responses with independent records (i.e. official hospital or medical documents) (Dex, 
1995). Unfortunately, this is not feasible for menstrual cycles, since medical records are not kept 
every time a woman menstruates, and thus, a test-retest methodology will be used.  
 
In the test-retest procedure, a repeat interview is carried out where participants are asked the 




then compared, examining gross and net difference rates between the responses of the two 
interviews (Foreman and Schreiner, 1991). Consistency between the structure and presentation 
of both interviews is important, since order and grouping of questions can influence responses 
and recall (Loftus et al., 1990).  
 
Regarding the accuracy of recall data, the retention of accurate memory relies largely on the 
subject matter being recalled (Dex, 1995). The more salient an event, the less error in recall, and 
the elapse of time is rather insignificant (Cannell and Henson, 1974; Mathiowetz and Duncan, 
1998). Personal events often follow a retention pattern of a hyperbolic or power function; recent 
memories are most accurate to recall, but then these decay in a stable manner over a long time 
(Rubin and Baddeley, 1989). While neutral events are known to have the worst recall capacity 
(Thompson, 1985), some studies have found pleasant events are recalled with more accuracy 
than unpleasant events (Skowronski, 1991), while others say they are recalled to the same extent 
(Thompson, 1985).  
 
In regard to menstrual cycles, it is likely the saliency and (un)pleasantness of the event is 
dependent upon the individual. However, given a girl’s first menstrual cycle is often a relatively 
shocking if not traumatic experience, it can be presumed that recall regarding the age of 
menarche should be fairly accurate. Other extenuating factors may also play a factor in recall, 
such as menstrual discomfort and pregnancy events. While it may be impossible for women to 
remember every time they experienced a menstrual cycle throughout their lifetime, it seems 
likely they would be able to recognize patterns of regularity or irregularity surrounding pertinent 
life events.  
 
In a review of studies regarding the retrospective recall error of the age of menarche against 
medical records, Holt et al. (1991) found a positive relation between magnitude of error and 
length of recall. When the recall was around four years, most errors (63%) were less than three 
months away from the real value, with a correlation between true and reported age to be 0.81 
(Bergsten-Brucefors, 1976). When recall was 39 years, only half (50%) of the errors were less 
than six months, and the correlation had decreased to 0.61 (Damon and Bajema, 1974). These 




around the true value, but Holt et al. also explicitly states “errors in recall of timing of events. . . 
may lead to very misleading estimates of duration distributions” (Holt et al., 1991, p. 2). Put into 
the context of this study, however, we are expecting a larger sample size across multiple ages to 
level out some of these errors.  
 
Other studies investigating recall reliability have found women to have greater accuracy in 
recalling certain life events. In a study of test-retest recall reliability regarding mammogram 
screening, Barratt (2000) found high validity with about a quarter (24.4%) of women recalling 
the exact date of their last mammogram and another third (39.4%) correctly reporting the month 
of their last mammogram. Almost all women (91.3%) reported the mammogram date accurately 
to within 12 months of that recorded within medical records (Barratt, 2000). Cherlin and 
McCarthy (1984) found women to be more accurate than men at recall of marital and fertility 
histories.  
 
Recall of physical activity has been studied widely, proving test-retest reliability as well as long-
term recall reliability valid (Blair, 1991; Brown, 2004; Falkner, 1999). Brown (2004) tested four 
self-reporting physical activity questionnaires, finding them valid for assessing activity level and 
sedentariness, and even a moderate reliability for total minutes of activity. Blair (1991) analyzed 
long-term recall reliability of physical activity against a baseline measurement 1-10 years after 
examination, finding a 60-75% agreement in recall. In this study, length of recall interval was not 
a contributing factor to error and recall of vigorous activity proved more accurate than less 
intense activity (Blair, 1991). Falkner (1999) tested long-term recall reliability of physical 
activity over 30 years and found large correlations including higher recall for females in more 
categories. Overall, research has shown test-retest reliability and long-term recall reliability to be 
high regarding women’s health histories and physical activity.  
 
2.4 The Health and Reproductive Survey (HeRS) 
 
The HeRS was designed to investigate the impacts of physical activity and sport history 
participation on reproductive health from menarche to current (Ackerman, in press). The survey 




exercise science, and survey measurement methods (Ackerman, in press). It is divided into sections 
based on age starting with (1) menarche/first period and ending with (5) current status/ ≥ 40 years. 
 
The first section of the survey regarding menarche gives primary focus to the age of first 
menstruation, physical activity level at the time, and familial (maternal and female siblings’) 
reproductive health. The following four sections contain the same repeating 138 questions in 
reference to the corresponding age range. The primary focus is on the regularity of the menstrual 
cycle, attributes surrounding this regularity within the age range (i.e., height and weight) and 
certain life events of lifestyle changes (i.e., changes in activity level, health diagnoses, pregnancy) 
that may have altered the menstrual cycle frequency, duration, or flow.  
 
The survey is 683 questions in total, although questions or entire sections may be skipped 
depending on the participant’s age and health history (Ackerman, in press). The survey takes 12-
15 minutes for native English speakers with at least a third-grade literacy level (Ackerman, in 
press). The survey was validated for face validity and content validity (Ackerman, in press). 
 
2.5 Limitations of the HeRS Due to Methods of Self-Report 
 
Since the HeRS is a self-reported questionnaire, there are limitations to the results and conclusions 
to be interpreted from this data. While the elapse of time shows to make little difference to the 
recall of salient events (Cannell and Henson, 1974) such as we would believe of menarche, it is 
expected that broader questions regarding the number of menstrual cycles per year and max/min 
height and weight will portray less reliability, especially within the older population recalling their 
youngest years. These questions not only ask for specific identifying metrics but ask for these 
values averaged or summated over a spanning period of time.  
 
Even if strong recall reliability is confirmed in this study, it is impossible to explain the accuracy 
of the data reported without the potential for comparison with independent records (Dex, 1995). 
This survey also maintains that respondents are honest about sensitive personal information such 




vulnerability that comes with some of these questions may provoke respondents to answer less 
truthfully or not divulge the extent of these events.  
 
The HeRS also asks respondents to self-identify as a recreational or competitive athlete upon 
distinct age frames, as well as report specific information on physical activity participation. It is 
well documented that social desirability bias can lead to over-reporting of physical activity 
(Warnecke et al, 1997). However, total and vigorous physical activity scores tend to have higher 
reliabilities (Sallis, 2000), which may more greatly support data regarding competitive athletes or 
highly active recreational athletes which we predict to be more likely amenorrheic.  
 
Finally, the HeRS has only so many control variables surrounding the connectivity between 
menstrual cycle regularity and physical activity participation. While questions regarding BMI and 
eating disorders provide some insight into other explanatory factors for menstrual irregularities, 
there are no questions regarding demographics, income, dietary practices (vegetarianism, 
veganism, paleo, etc.) which have shown to impact menarche (Karapanou & Papadimitriou, 2010), 
thus have the potential to play a role in lifelong menstrual cycle patterns. Assumptions and 
conclusions collected from this data must be approached with caution, and further investigation 








3.1 Experimental Design 
 
This study uses a retrospective self-reported online survey in a test-retest design across a 4-
month time span to investigate recall validity of the HeRS. Survey data from this bout of 




3.2 Subject Characteristics  
 
The survey can be completed by all women at or above the age of 18. The questionnaire is 
designed to be completed within 12-15 minutes for native English speakers with at least a third-
grade literacy rate.  
 
 
3.3 Testing Procedures 
 
The HeRS was first opened for purposes of this study at Timepoint 1 on August 9th, 2020. 
Recruitment emails with a link to the HeRS was sent to a convenience sample of groups, 
organizations, and individual contacts believed to have broad access to women (i.e., coaches, 
athletes, medical students, business students, etc.). Within the recruitment email was a request to 
forward the survey on to any other women that may be inclined to participate. Reminders were 
administered 1 week later to all those who opened the link but did not entirely complete the 
survey. The survey was closed on September 1st, 2020.  
 
The survey was opened again for Timepoint 2 on December 1st, 2020, and emails were sent out 




immediately were sent reminder emails one week, two weeks, and three weeks following. The 
survey was closed on January 1st, 2021.  
 
 
3.4 Statistical Analysis 
 
All descriptive data analyzed in the study was presented as mean ± SD. The statistics for each of 
the hypothesis of this study is described individually, below. A priori statistical significance is 
set at p<0.05. 
 
To answer the first aim of this study, we excluded HeRS questions from analysis if: 1) they did 
not provide valuable information about reproductive health recall for the current thesis, 2) 
questions were added prior to the second survey administration (T4mo), 3) showed poor survey 
design leading to unreliable respondent answers or 4) did not have enough responses to give 
meaning to the recall statistics. All remaining survey questions within the first four sections (first 
menarche (M), 13-18 (HS), 18-24 (C), and 25-40 (PC)) were compared between Timepoint 1 
(T1) and Timepoint 2 (T4mo) to determine the test-retest recall validity. Depending on the 
question type, it was run as limits of agreement (LOA) or Cohen’s kappa coefficient. Limits of 
agreement was used on all questions of value (i.e. height, weight, questions with number ranges) 
to determine how closely responses agreed between T1 and T4mo. Cohen’s kappa was used on 
all yes/no and categorical questions, and took into account the probability of respondents 
answering the same way at each Timepoint by chance.  
 
Cohen’s kappa agreement analysis was done assessed using to the following cut points: 0 = 
agreement equivalent to chance; 0.1 – 0.20 = slight agreement; 0.21 – 0.40 = fair agreement; 
0.41 – 0.60 = moderate agreement; 0.61 – 0.80 = substantial agreement; 0.81 – 0.99 = near 
perfect agreement; 1 = perfect agreement. 
 
The second research question followed the same procedures as the previous but only after 




agreement and Cohen’s kappas was calculated on each question of the first section of the HeRS 
regarding menarche (M).  
 
For the third objective regarding the correlation of physical activity level and BMI with age at 
menarche, correlation statistics examined the relationship between question 1.1 (“How old were 
you the first time you had your period”) to question 1.15 (“Around the time of your first period, 
how many hours per week were you physically active, on average?”). Questions regarding the 
respondents’ height and weight at the time of their first menstrual cycle were used to calculate 
BMI.  
 
The fourth research question regarding physical activity level and menstrual irregularities took 
into account both the average annual number of menstrual cycles respondents had (“Between the 
ages of ‘’ and ‘’, approximately how many periods did you have per year, on average?”) as well 
as whether the respondents were ever formally diagnosed with a menstrual disorder (amenorrhea, 
oligomenorrhea, female athlete triad (FAT), or relative energy deficiency in sport (RED-S)). 
Respondents were bucketed into groups based on whether they identified as competitive athlete, 
recreational athletes, or non-athletes. Within these groups, they were analyzed based on 
menstrual cycle number and physical activity hours, as well as the frequency of menstrual 
disorder diagnosis.  
 
The fifth objective explored the relationship between a change in physical activity level and 
menstrual cycle characteristics. We analyzed the questions regarding how changes in physical 
activity (“Between the ages of ‘’ and ‘’, how did your menstrual cycle change when you 
INCREASED/DECREASED your physical activity?”) and calculated the frequency of responses 
regarding menstrual cycle characteristic changes based on intensity, duration, and frequency (“I 
bled less, I bled more, I bled fewer days”, etc.,) to determine general association trends.   
 
For the sixth, and final, research question regarding the prevalence of birth control use, we 
analyzed the frequency of birth control use across survey section age ranges (M, HS, C, PC) and 
then analyzed these frequencies grouped by self-identified athlete type (competitive athlete, 




No testing for statistically significant differences was completed for any of the aims. Purely 




















4.1 Subject Characteristics 
 
In total, 144 respondents fully completed the Health and Reproductive Survey at both timepoints 
(the initial survey (T1) and 4months later (T4mo)). The average age of the respondents was 




Figure 2. Frequency of HeRS Respondents by Current Age (Reported at T4mo) 
 
The majority of participants (76.4% of respondents) reported reaching menarche at a normal age 
(between the ages of 12-15; only categorical variables given as choice), with their first menstrual 
cycle lasting 2-7 days (72.2% of respondents), getting their next menstrual cycle within six 
months (81.9% of respondents), and having their menstrual cycle occur on a regular basis (every 





Average BMI at the age of menarche was 20.15 +/- 2.884 (n=97), with a minimum of 12.86 and 
a maximum of 36.56. A total of 58.3% of respondents reported at least one biological sister. Of 
these sisters, 114 had some level of data reported by the respondent. Respondents reported that 
they knew the age range of menarche for 84.2% of their sisters. Only 29.9% of respondents 
reported an exact age for when their mothers reached menarche.  
 
At the time of menarche, 82.6% of respondents reported being physically active. The majority of 
respondents reported being physically active 5-10 hours per week (30.6%), with the next largest 
group reporting 11-15 hours of physical activity per week (20.1%). When reporting the hours of 
physical activity performed on average at the time of menarche by value instead of categorically 
(T4mo; this question was altered in second recall to provide some clarity on baseline responses), 
the average was 8.45 +/- 6.05 hours. At the time of menarche, 41.9% of respondents self-
identified as competitive athletes, 24.3% as recreational athlete, and 34% as non-athletes. The 
number of self-identified competitive athletes increased in the high school age section of the 
survey (13-18 years) to 54.2%, and progressively decreased into post-college age with only 6.3% 
(n=x out of a total of 114 respondents for this age group) of respondents self-identifying as 
competitive athletes.  
 
Related to birth control use, 86.1% of respondents reported having ever used a form of birth 
control (excluding condom use), with a majority of these (62.9% of respondents) reporting to 
have experienced some sort of side effects with the use of birth control. The primary form of 
birth control used within every age range was oral contraceptives.  
 








4.2 Recall Reliability 
 
4.2.1 Excluded Questions from Recall Reliability Testing 
HeRS questions were dropped from recall reliability testing if they did not provide significant 
insight into the recall of reproductive events (i.e., “How many biological sisters do you have?”) 
or reflected survey design issues that skewed reliability of respondents’ answers.  
 
Appendix C shows the complete list of dropped questions and variables from recall reliability 
analysis, as well as the reasoning behind doing so.   
   
 
4.2.2. Survey Recall Reliability  
Questions regarding side effects experienced from birth control, increases/decreases in physical 
activity level causing a change in menstrual cycle characteristics, menstrual cycle symptoms that 
caused one to miss a training or sports competition, reported diagnosis of medical conditions, 
and types of birth control used were each organized into categorical variables and analysis tested 
whether respondents checked the same value range of boxes per question for each T1 and T4mo.   
 
Cohen’s Kappas (Kappas) were run on all categorical survey questions, while Limits of 
Agreement (LOA) calculations were run for survey questions with a linear scale. The limits of 
agreement analysis provide insight into the absolute error for each question between T1 and 
T4mo.  
 
Tables 2-5 show the Kappas and LOAs of recall reliability for each section of the HeRS 
(menarche (M); high school age years (HS), 13-18; college age years (C), 18-24; and post-
college years (PC), 25-40). Chi square charts for each question can be found in Appendix D.  
 
Recall of age at menarche showed significant agreement in responses between survey timepoints 
(Kappa=0.832; Near perfect agreement). LOA values for height and weight both reveal poor 
recall (Height: 0.455 +/- 6.331, mean difference in min height reported; mindiffht=-7.6 cms, mean 




15.88 kgs, maxdiffwt=22.68 kgs), with large standard deviations and huge variations in the 
minimum and maximum reported across the recall timeframe. Recall of the length of 
respondents’ menstrual cycle, time before the second menstrual cycle, and whether their cycle 
became regular post-second menstrual cycle all showed moderate or fair-moderate agreement 
(see Table 2).  
 
Recall of physical activity (PA) status (very physically active, somewhat physically active, or not 
physically active) showed near perfect agreement (kappa=0.9), while recall of hours of physical 
activity per week had only fair agreement (0.323). Recall of ever experiencing side effects with 
birth control was near perfect (0.845), while the categorized variable used to count for the 
number of selected side effects by the respondents was substantial (0.711).  
 
Recall of high weight, low weight, and height by respondents became more reliable at the older 
age ranges of the survey (PC: high weight: LOA=0.1325 +/- 5.4425; low weight: LOA=-0.158 
+/- 6.1816; height: LOA=0.1768 +/- 3.00488), however the minimum and maximum values still 
showed high variability in responses (PC: high weight: -12.7 kgs, 7.71 kgs; low weight: -9.07 
kgs, 17.69 kgs; height: -8.89 cms, 6.35 cms).  
 
Recall of average number of menstrual cycles per year remained relatively stable between survey 
sections (HS: 0.551, Moderate agreement; C: 0.559, Moderate-substantial agreement; PC: 0.527, 
Moderate agreement). Recall of whether one’s period stopped increased with age but was 
significant across age ranges of the survey sections (HS: 0.605, Moderate-substantial agreement; 
C: 0.808, Near perfect agreement; PC: 0.873, Near perfect agreement), while the longest length 
of time one’s period stopped showed highly variable responses (HS: 1.4545 +/- 13.1410; C: -
0.2632 +/- 24.7132; PC: 0.5652 +/- 9.7790).  
 
Regarding the impact of physical activity level on menstrual cycle characteristics (i.e. intensity, 
duration, and flow), recall reliability kappa values of the yes/no answer to whether PA impacted 
cycle changes revealed moderate-substantial agreement across survey sections (PA increase, PA 
decrease; HS: Substantial, Moderate; C: Moderate, Moderate; PC: Substantial, Moderate), while 




changes in PA revealed (PA increase, PA decrease; HS: Substantial; C: Moderate; Moderate, 
Moderate; PC: Substantial, Moderate). 
 
Recall reliability of being diagnosed with a medical condition (menstrual cycle disorder, eating 
disorder, etc.) revealed substantial agreement throughout survey section age ranges (HS: 0.577, 
Substantial agreement; C: 0.636, Substantial agreement; PC: 0.622, Moderate-Substantial 
agreement).  
 
Lastly, the use of birth control (yes/no) and the form of birth control used (categorical variable) 
both revealed high agreement between recall timepoints (yes/no: HS: 0.90, Near perfect; C: 0.81, 
Substantial-Near perfect; PC: 0.762, Substantial | categorical variable: HS: 0.803, Substantial-
Near perfect; C: 0.749, Substantial; PC: 0.62, Moderate-Substantial). 
 
 





















How old were you the first time 







    
weight 
Approximately how much did you 
weigh the first time you had your 
period? Please report in pounds 
(exclude units). If you do not 
remember, please write I cannot 
remember. 
















Approximately how tall were you 
the first time you had your 
















(exclude units).  If you do not 
remember, please write I cannot 
remember. 
CONVERTED TO CMs 
first_period 
How many days did your first 





    
second_period 
After your first period stopped, 







    
regularity 
After your second period, did 
your periods start to occur on a 






    
mom_period 
How old was your mother when 
she got her first period? If you do 















How old was your sister when she 
got her first period? If you do not 





    
Sister 2 
How old was your sister when she 
got her first period? If you do not 





    
Sister 3 
How old was your sister when she 
got her first period? If you do not 






    
physical_activity 
Which of the following best 
describes your physical activity 







    
activity_hours 
Around the time of your first 
period, how many hours per week 






    
activity_change 
After your first period but before 









physical activity patterns 
CHANGE? 
side_effects 
Have you ever experienced any 
side effects from taking any form 






    
SIDE_EFFECT_categorized 
(A variable created to analyze the 
number of birth control side 






    
 
 
Table 3. Cohen’s Kappas and Limits of Agreement for the HeRS section HS, Ages 13-18 (High 



































At what age did you end, 
















What is/was your highest 
weight (excluding pregnancy 
weight) between the ages of 13 
and 18? Please report in pounds 
(exclude units). If you do not 


















What is/was your lowest weight 
between the ages of 13 and 18? 
Please report in pounds (exclude 
units). If you do not remember, 


















Between the ages of 13 and 18, 



















Between the ages of 13 and 18, 
did your periods ever stop for 
2+ months without the use of a 
contraceptive means and/or in 






    
hs_age_period_stop 
Between the ages of 13 and 18, 
how old were you the first time 
your periods stopped for 2+ 
months without the use of a 
contraceptive means and/or in 















Between the ages of 13 and 18, 
what was the longest length of 
time you went without a period 
without the use of a 
contraceptive means and/or in 
the absence of pregnancy? 















Between the ages of 13 and 18, 
did your menstruation change 






    
HS_PA_INC_categorized 
How did your menstrual cycle 
change when you INCREASED 





    
hs_pa_decrease 
Between the ages of 13 and 18, 
did your menstruation change 






    
HS_PA_DEC_categorized 
How did your menstrual cycle 
change when you 






    
hs_miss_pa 
Between the ages of 13 and 18, 









training session or sport 
competition because of your 
menstrual cycle or related 
symptoms? 
HS_MISS_PA_categorized 
Between ages 13-18 which 
symptoms prevented you from 





    
hs_high_performance 
Between the ages of 13 and 18, 
was there a point in your 
menstrual cycle when you could 
physically perform at a 







    
HS_HIGH_PERF_values 
Between 13-18, when during 
menstrual cycle did you perform 





    
hs_low_performance 
Between the ages of 13 and 18, 
was there a point in your 
menstrual cycle when you could 
physically perform at a LOWER 





    
HS_LOW_PERF_values 
Between 13-18, when during 
menstrual cycle did you perform 
at HIGHER level? 1-Beginning, 







    
HS_MEDICAL_CONDITION 
Between 13-18, were you 
diagnosed with any of the 





    
hs_bc 
Between the ages of 13 and 18, 
did you use any form of birth 







    
HS_BC_TYPE_values 













Table 4. Cohen’s Kappas and Limits of Agreement for the HeRS section C, Ages 18-24 (College 





















What is/was your highest weight 
(excluding pregnancy weight) 
between the ages of 18 and 24? 
Please report in pounds (exclude 
units). If you do not remember, 
















What is/was your lowest weight 
between the ages of 18 and 24? 
Please report in pounds (exclude 
units). If you do not remember, 















Approximately how tall were you 
between the ages of 18 and 24? 
Please report in inches (exclude 
units).  If you do not remember, 
















Between the ages of 18 and 24, 
approximately how many periods 






    
college_period_stop 
Between the ages of 18 and 24, did 
your periods ever stop for 2+ 
months without the use of 







    
college_period_stop_age 
Between the ages of 18 and 24, how 
old were you the first time your 
periods stopped for 2+ months 
without the use of contraception 


















Between the ages of 18 and 24, 











you went without a period without 
the use of contraception and/or in 
the absence of pregnancy? Please 









Between the ages of 18 and 24, did 
your menstruation change when 






    
COLLEGE_PA_INC_categorized 
How did your menstrual cycle 
change when you INCREASED 





    
college_pa_decrease 
Between the ages of 18 and 24, did 
your menstruation change when 






    
COLLEGE_PA_DEC_categorized 
How did your menstrual cycle 
change when you DECREASED 





    
college_pa_miss 
Between the ages of 18 and 24, did 
you ever have to miss a training 
session or sport competition 






    
COLLEGE_MISS_PA_categorized 
Between ages 13-18 which 
symptoms prevented you from 





    
college_high_performance 
Between the ages of 18 and 24, was 
there a point in your menstrual 
cycle when you could physically 






    
COLLEGE_HIGH_PERF_values 
Between 19-24, when during 






    
college_low_performance 
Between the ages of 18 and 24, was 
there a point in your menstrual 









performed at a LOWER level than 
your normal? 
COLLEGE_LOW_PERF_values 
Between 19-24, when during 
menstrual cycle did you perform at 





    
COLLEGE_MEDICAL_CONDITI
ONS 
Between 18-24, were you 







    
college_bc 
Between the ages of 18 and 24, did 
you use any form of birth control 






    
COLLEGE_BC_TYPE_VALUES 







    
 
 
Table 5. Cohen’s Kappas and Limits of Agreement for the HeRS section PC, Ages 25-40 (Post-





















What is/was your highest weight 
(excluding pregnancy weight) 
between the ages of 25 and 40? 
Please report in pounds (exclude 
units). If you do not remember, 

















What is/was your lowest weight 
between the ages of 25 and 40? 
Please report in pounds (exclude 
units). If you do not remember, 
















Approximately how tall were you 
between the ages of 25 and 40? 



















units).  If you do not remember, 
please write I cannot remember. 
pc_period_number 
Between the ages of 25 and 40, 
approximately how many periods 





    
pc_period_stop 
Between the ages of 25 and 40, did 
your periods ever stop for 2+ 
months without the use of 







    
pc_period_stop_age 
Between the ages of 25 and 40, how 
old were you the first time your 
periods stopped for 2+ months 
without the use of contraception 


















Between the ages of 25 and 40, 
what was the longest length of time 
you went without a period without 
the use of contraception and/or in 
the absence of pregnancy? Please 


















Between the ages of 25 and 40, did 
your menstruation change when you 







    
PC_PA_INC_categorized 
How did your menstrual cycle 
change when you INCREASED 






    
pc_pa_decrease 
Between the ages of 25 and 40, did 
your menstruation change when you 






    
PC_PA_DEC_categorized 
How did your menstrual cycle 
change when you DECREASED 





    
pc_pa_miss 
Between the ages of 25 and 40, did 









session or sport competition 
because of your menstrual cycle or 
related symptoms? 
PC_MISS_PA_categorized 
Between ages 25-40 which 
symptoms prevented you from 






    
pc_high_performance 
Between the ages of 25 and 40, was 
there a point in your menstrual 
cycle when you could physically 







    
PC_HIGH_PERF_values 
Between 19-24, when during 






    
pc_low_performance 
Between the ages of 25 and 40, was 
there a point in your menstrual 
cycle when you physically 






    
PC_LOW_PERF_values 
Between 19-24, when during 








    
PC_MEDICAL_CONDITION_valu
es 
Between 25-40, were you diagnosed 








    
pc_bc 
Between the ages of 25 and 40, did 
you use any form of birth control 






    
PC_BC_TYPE_values 













4.3 Recall Reliability of Menarche Questions by Current Age 
 
Cohen’s Kappas and limits of agreement of the first section of the survey (questions regarding 
menarche), were analyzed by current age, providing information related to whether older or 
younger individuals had better recall reliability. Table 6 shows the results of this analysis. 
 
Recall reliability for the menarche section of the HeRS based on current age showed very mixed 
results. Younger populations (18-24, n=30) had the strongest recall reliability for some 
questions, other questions had the strongest recall reliability in the oldest population (35+, n=36), 
while other questions had the best recall reliability in the mid-range age groups (25-29, n=48; 30-
34, n=28).  
 
Regarding age at menarche, the mid-range age group of 30-34 was the only group with perfect 
agreement (kappa=1), while the oldest and youngest groups had near perfect agreement, and the 
25-29 age range had substantial agreement (kappa=0.766). The youngest age group showed 
greatest recall reliability regarding the regularity of one’s cycle after their second period 
(kappa=0.667, Substantial agreement), but the lowest recall reliability related to side effects 
experienced from taking birth control (0.751, Substantial agreement; age ranges 25-10, 30-34, 
35+ = Near perfect agreement).  
 
Regarding physical activity level at the time of menarche, agreement was high in all age ranges 
when asked the categorical question (Which of the following best describes your physical 
activity level at the time of your first period? Very physically active, somewhat physically active, 
not physically active) (18-24=Perfect agreement, 25-29=Substantial agreement, 30-34=Near-
perfect agreement, 35+=Perfect agreement), but low regarding the exact number of physical 
activity hours per week (18-24=Slight agreement, 25-29=Fair agreement, 30-34=Moderate 
agreement, 35+=Fair agreement). The older age ranges had the best agreement regarding hours 
of physical activity per week at the time of menarche with 30-34=0.5, moderate agreement and 




The question regarding change in activity level between one’s first and second period showed no 
agreement for the first two age groups (18-24=-0.015; 25-29=0.111), and fair agreement in the 
older two age groups (30-34= 0.288; 35+= 0.311).  
 
 
Table 6. Cohen’s Kappas and Limits of Agreement to the HeRS section M, Regarding Menarche, 











Question     
(first_period_age) 
How old were you 
the first time you 















much did you weigh 
the first time you 
had your period? 
Please report in 
pounds. If you do 
not remember, 








































much did you weigh 
the first time you 
had your period? 
Please report in 
pounds. If you do 
not remember, 
please write I cannot 
remember. 
LOA: 














much did you weigh 
the first time you 
had your period? 
Please report in 
pounds (exclude 





















write I cannot 
remember. 
(second_period) 
After your first 
period stopped, 
when did you get 


















After your first 
period stopped, 
when did you get 


















After your first 
period stopped, 
when did you get 






.0333 +/- .4806 
 
LOA: 











level at the time of 














Around the time of 
your first period, 
how many hours per 
week were you 


















After your first 
period but before 
your next period, 




















Have you ever 
experienced any 
side effects from 






















4.4 Physical Activity Level and BMI relation to Age at Menarche 
 
Respondents (76%) reported reaching menarche between the ages of 12-15, while 16.7% of 
respondents reported reaching menarche at age 11 or younger, and 6.9% of respondents reported 
reaching menarche at age 16 or older (indicative of primary amenorrhea).  
 
The average reported hours of physical activity around the time of menarche were 8.45 +/- 6.05 
hours (activity_hours_4mo). At the time of menarche, 41.9% of respondents self-identified as 
competitive athletes, 24.3% as recreational athlete, and 34% as non-athletes.  
 
Figure 3 groups respondents based on their age at menarche layered by whether they self-
identified as a competitive athlete, recreational athlete, or non-athlete, and plots the average, max 




Figure 3. Reported Age at Menarche by Average Hours of Physical Activity Being Performed 






Average BMI at the age of menarche was 20.15 +/- 2.884, with a minimum of 12.86 and a 
maximum of 36.56. Only 67.4% (n=97) of respondents reported a BMI at menarche, while the 
number of respondents that could not remember either their weight (n=42) and/or height (n=34) 
at menarche was significant. Full descriptive data for these variables can be found in the 
demographics section of Appendix B. 
 
Figure 4 groups respondents based on their age at menarche layered by whether they self-
identified as a competitive athlete, recreational athlete, or non-athlete, and plots the average, max 




Figure 4. Reported Age at Menarche by BMI in Self-Identifying Competitive Athletes, 









4.5 Physical Activity Level by Number of Menstrual Cycles of Competitive Athletes and 
Disordered Cycles 
 
The majority of respondents reported a regularly occurring menstrual cycle (10-12 cycles per 
year) at each age range (HS: 56.9%; C: 58.3%; PC: 50%, n=108). Among exclusively 
competitive athletes, the majority still reported a regularly occurring menstrual cycle at each age 
group (HS:59.0%, n=78; C: 64.6%, n=48; PC:46.2%, n=13).  
 
The average range of hours of physical activity performed by competitive athletes during the 
high school age was 10.6 +/- 3.54 (n=78), during the college age was 14.5 +/- 4.70 (n=48), and 
during the post-college age was 3.4 +/- 6.53 (n=13). Figure 5 shows the average number of 
menstrual cycles based on physical activity and survey recall age group. 
 
Full descriptive data of these variables can be found in the demographics section of Appendix B. 
 
 
Figure 5. Average Number of Menstrual Cycles Per Year by Average Physical Activity Level at 
the High School Age (13-18), College Age (18-24), and Post-College Age (25-40) of Self-




The number of all respondents diagnosed with menstrual cycle disorders increased from 26 
during the high school age range (18.1%, N=144) to 39 during the college age range (27.1%, 
N=144). This number stabilized into the post-college age range, with 39 respondents (36.1%, 
N=108) reporting diagnosed menstrual cycle disorders well into adulthood (see Table 7). 
 
 
Table 7. Percentage of Respondents per Age Range Diagnosed with Disordered Menstrual 
Cycles (Amenorrhea, Oligomenorrhea, Polymenorrhea, Female Athlete Triad, or RED-S).   
 Respondents Diagnosed with Disordered Menstrual Cycles 

























The most common diagnosed menstrual cycle disorder reported by respondents is shown in 
Table 8. Across all age ranges, amenorrhea (HS:16%, n=23; C: 25%, n=36; PC: 27%, n=39), and 
the female athlete triad (HS: 2.8%, n=4; C:6.3%, n=9; PC: 3.5%, n=5) were the most commonly 
diagnosed menstrual cycle disorders. 
 
 
Table 8. Percentage of Respondents Diagnosed with Disordered Menstrual Cycles (Amenorrhea, 
Oligomenorrhea, Polymenorrhea, Female Athlete Triad, or RED-S) During HS, C, and PC.  









 n % n % n % 
Amenorrhea 23 16% 36 25% 39 27% 




Polymenorrhea 1 0.7% 1 0.7% 0 0% 
Female Athlete Triad 4 2.8% 9 6.3% 5 3.5% 
RED-S 3 2.1% 6 4.2% 2 1.4% 
*respondents could mark multiple diagnosis within each age range 
 
 
Of those diagnosed with menstrual cycle disorders at the high school age range, non-athletes 
showed the highest percentage of diagnosed disordered cycling (31.4%, n=11/26) while 
recreational athletes showed the highest percentage of diagnosed disordered cycling within the 
college and post-college age ranges (C: 34.4%, n=22/39; PC: 37.5%, n=27/39) (see Table 9). 
 
 
Table 9. Frequency of Menstrual Cycle Disorder Diagnosis by Self-Identified Athlete Status. 
 
 











n % n % n % 
Competitive Athlete 7 26.9% 11 28.2% 3 7.7% 
Recreational Athlete 8 30.8% 22 56.4% 27 69.2% 
Non-Athlete 11 42.3% 6 15.4% 9 23.0% 






4.6 Change of Physical Activity Levels and Characteristics of Menstrual Cycle 
 
Analysis revealed that nearly a third of all respondents (30.6%) had noticeable changes to their 
menstrual cycle characteristics (i.e., intensity, frequency, and duration) when they increased their 
physical activity level between the ages of 13-18 (see Table 10). This percentage of respondents 
decreased between the ages of 18-24 (12.5%), then increased again to nearly the same level at 
the age range of 25-40 (N=114, 29.6%). The percentage of respondents that reported noticeable 
changes to menstrual cycle characteristics attributed to a decrease in physical activity was much 
lower across all age ranges (13-18: 12.5%; 18-24: 17.4%; 25-40: 19.4%).  
 
 
Table 10. Reported Noticeable Changes to Menstrual Cycle Characteristics During an Increase 
or Decrease in Physical Activity Levels Throughout Survey Age Range Sections. 
  
Survey section age groups 
13-18 18-24 25-40* 
 
Did your menstruation 





























Did your menstruation 


































The most common menstrual cycle characteristics reported with an increase in physical activity 
were decreased frequency (22.2%), followed by decreased intensity (7.6%) and duration (7.6%). 
The most common menstrual cycle characteristics reported with a decrease in physical activity 
was an increase in frequency (8.3%) followed by an increase in intensity (7.6%) (see Table 11).  
 
 
Table 11. Menstrual Cycle Characteristics Influenced by an Increase or Decrease in Physical 
Activity Across Survey Section Age Ranges. 
 Survey section age group 
13-18 18-24 25-40* 
 
How did your 
menstruation change 
when you INCREASED 
your physical activity? 





































How did your 
menstruation change 
when you DECREASED 
your physical activity? 











































4.7 Women Reporting the Use of Birth Control by Athletic Self-Identification 
 
Out of the total 144 respondents, 86.11% said they had used some form of birth control besides 
condoms at some point during their life. 
 
During the high school age years (13-18), recreational athletes were the highest subgroup which 
reported using birth control (54.3%; n=35) followed closely by non-athletes (51.6%; n=31), and 
then by competitive athletes (33.3%; n=78). The number of respondents that identified as 
competitive athletes dropped significantly into the college age range (from n=78 to n=48) as the 
number of recreational athletes increased (n=35 to n=64). This time period had the highest 
overall reported use of birth control across athlete type (comp=62.5%; rec=78.1%; non=78.1%). 
By the post-college age years (25-40; n=114), recreational athletes remained the largest group by 
athlete type (n=75) and had the highest percentage of birth control use (64%). The number of 
competitive athletes within this age group decreased even further (n=14), with half reporting the 
use of birth control (50%).   
 
Across age ranges and athlete self-identification types, oral contraceptives were the most widely 
used form of birth control (see Tables 12-17) (HS: comp=28.3%, rec=45.7%, non=32.3%; C: 
comp=56.3%, rec=45.3%, non=59.4%; PC: comp=35.7%, rec=37.3%, non=23.7%).  
 
 
Table 12. Birth Control Use by Self-Identified Athlete Type Between Ages 13-18 (High School 
Age Years) 
 Respondents’ use of birth control 
Self-identified Athlete Type YES NO 
Competitive Athlete (n=78) 33.3% 66.7% 
Recreational Athlete (n=35) 54.3% 45.7% 








Table 13. Form of Birth Control Used by Self-Identified Athlete Type Between Ages 13-18 
(High School Age Years) 





Oral contraceptive 28.3% 
Non-oral contraceptive 1.3% 
Other 1.3% 
Multiple forms of BC during this time frame 5.1% 
None 59% 




Oral contraceptive 45.7% 
Non-oral contraceptive 0% 
Other 0% 





Oral contraceptive 32.3% 
Non-oral contraceptive 0% 
Other 3.2% 





Table 14. Birth Control Use by Self-Identified Athlete Type Between Ages 18-24 (College Age 
Years) 
 Respondents’ use of birth control 
Self-identified Athlete Type YES NO 
Competitive Athlete (n=48) 62.5% 37.5% 
Recreational Athlete (n=64) 78.1% 21.9% 





Table 15. Form of Birth Control Used by Self-Identified Athlete Type Between Ages 18-24 
(College Age Years) 





Oral contraceptive 56.3% 
Non-oral contraceptive 2.1% 
Other 0% 
Multiple forms of BC during this time frame 6.3% 
None 27.1% 




Oral contraceptive 45.3% 
Non-oral contraceptive 3.1% 
Other 1.6% 





Oral contraceptive 59.4% 
Non-oral contraceptive 9.4% 
Other 0% 





Table 16. Birth Control Use by Self-Identified Athlete Type Between Ages 24-40 (Post-College 
Age Years) 
 Respondents’ use of birth control 
Self-identified Athlete Type YES NO 
Competitive Athlete (n=14) 50% 50% 
Recreational Athlete (n=75) 64% 36% 






Table 17. Form of Birth Control Used by Self-Identified Athlete Type Between Ages 24-40 
(Post-College Age Years) 





Oral contraceptive 35.7% 
Non-oral contraceptive 7.1% 
Other 0% 





Oral contraceptive 37.3% 
Non-oral contraceptive 17.3% 
Other 1.3% 





Oral contraceptive 23.7% 
Non-oral contraceptive 5.3% 
Other 0% 










5.1 General Findings about the Health and Reproductive Survey 
 
5.1.1. Excluded questions from recall analysis and other analysis, and suggestions for edits to the 
HeRS before future administration 
HeRS questions were dropped from recall reliability testing if they did not provide valuable 
insight into survey recall (i.e., The Cohen’s Kappa of complete agreement regarding the question 
“How many biological sisters do you have?” carries little weight in the grand scheme of 
reproductive surveys), or when survey design or poor wording of questions resulted in skewed 
and unreliable respondent responses. The justification for each follows.  
 
With regard to the wording of questions, an excellent illustrative example is the question related 
to height between the ages of 13-18 (hs_height). While this same section asked for the 
respondent’s highest and lowest weights during high school, it did not do the same thing for 
height. While this may make sense in other sections of the survey when adult height has been 
attained and the female is fully grown, ages 13-18 represents a developmental window that 
encompasses linear growth for most girls, thus a significant change in height across this age 
range is likely. Therefore, respondents may have answered this question by taking their average 
height, their height at age 13 or their height at age 18. This was evidenced by a Cohen’s Kappa 
for height between the ages of 13-18 with no agreement, and the LOA was extremely poor (-
0.3909 +/- 8.39, min=-20.32, max=8.39).  
 
Another question - as well as the categorical variable created with it during analysis - was 
assessing changes in menstrual cycle characteristics (duration, flow, frequency, etc.) 
(hs_pa_change) due to changes in physical activity. While the Cohen’s Kappa for this variable 
was substantial, respondents showed contradictions in answering this question and the questions 
that followed asking more specifically about an increase or decrease in physical activity. For 
example, some respondents answered “no” to the question about whether they experienced a 




whether they experienced a change in menstrual cycle due to an increase/decrease in physical 
activity. The directionality of the latter questions provided more specific information and makes 
interpretation of the data collected on the first question problematic—since it combines 
directionality (increased and decreased) into a single question.  
  
After the first round of data collection, clarity around athletic performance and physical activity 
participation was needed. Several questions were added related to self-identification of 
respondents as a competitive or recreational athlete, and questions pertaining to the number of 
days and hours of physical activity/exercise/training pertaining to these sports. Since these 
questions were added to the second recall (T4mo), there was no way to calculate recall reliability 
for these questions and thus, they were dropped from this section of the analysis. 
 
Some of these questions excluded from recall reliability analysis were used in subsequent 
analysis regarding physical activity at menarche, physical activity and corresponding number of 
menstrual cycles/diagnoses of disordered cycles, and self-identified athlete type related to birth 
control use. Other questions were excluded from analysis altogether. For instance, type of sport 
participation was not used at all within this analysis, and all data regarding recreational sport 
hours of participation were disregarded. These latter questions were excluded from all analysis 
because it became evident that the wording of the questions (regarding the number of days per 
week and hours per day of physical activity) led to misinterpretation of the question by many 
respondents, since values reported exceeded reasonable amounts of exercise time per week (i.e., 
46 hours or 38 hours). This issue is not uncommon with self-report physical activity 
questionnaires, since many surveys report capping or eliminating data that seems excessive for 
exercise participation (Reifsteck, 2021). 
 
Other criticisms and necessary changes to be considered for the HeRS before future 
administration include the overlap of age for high school (13-18) and college (18-24) sections, as 
well the need to include questions on activity level within each age section. Regarding the 
overlap of the high school and college age range (13-18) and (18-24), since both include 18, this 
is confusing for respondents. One of these needs to be changed; either the high school age should 




competitive or recreational athlete physical activity hours were added to the HeRS T4mo, 
respondents were only questioned about their physical activity participation at the time of 
menarche. Meanwhile these sections still asked other questions regarding physical activity’s 
impact on one’s menstrual cycle characteristics and whether they were diagnosed with menstrual 
cycle disorders relative to energy availability, yet they never asked to clarify average intensity or 
number of hours of physical activity participation within these age ranges outside of menarche. 
Adaptations to these questions should be considered before the next administration of the HeRS.  
 
Finally, the length and repetitive nature of questions within each section of the HeRS should be 
acknowledged. Certain questions do not provide additional valuable information but instead add 
to the repetitive nature of the survey, leading to potential frustration for the respondent. For 
instance, the question regarding how a change in physical activity impacts menstrual 
characteristics could be dropped since the questions immediately following this ask specifically 
how an increase or decrease of physical activity impacts menstrual characteristics. Other 
questions that revealed low recall reliability and that may not provide much insight into analysis 
such as the age at which periods may have stopped for 2+ months and the longest length of time 
that periods stopped, should be considered for removal. Making the survey shorter in these areas 
could reduce survey fatigue and provide more accurate responses (Sinickas, 2007).  
 
5.1.2. Innovative questions and information gathered by the HeRS 
Evident from the lack of existing research, the HeRS is an innovative approach at observing the 
reproductive health history of women above the age of 18. The HeRS investigates topics of 
physical activity impacts on menstrual and reproductive health, the use of birth control among 
athletes and non-athletes and the reasoning for use, and the long term reproductive and health 
implications for disordered menstrual cycling especially at early ages, which are largely 
nonexistent in existing literature.  
 
The HeRS includes questions regarding the physical activity level of adolescents at menarche, 
which could provide significant insight into primary amenorrhea and whether there is a direct 
correlation with energy availability issues related to participation in physical activity, exercise or 




characteristics of one’s menstrual cycle (frequency, duration, intensity) which is rarely discussed 
within existing literature. The current literature largely classifies individuals as having/not 
having amenorrhea, without looking at other cycle characteristics that could correlate to rates of 
other menstrual irregularities that are not reflected by the categorization of amenorrhea.  
 
Finally, the HeRS may be one of the first surveys to investigate why individuals use birth control. 
This could provide significant insights into which competitive and recreational athletes, and what 
age groups, are using birth control for pregnancy avoidance, regulating menstrual cycles around 
competitions or because they were prescribed it by their physician due to concerns related to 
amenorrhea or the female athlete triad. Although beyond the scope of this thesis, future studies 
of these HeRS questions should be analyzed.   
 
 
5.2 Recall Reliability 
  
As predicted, recall of age at menarche showed significant agreement between survey timepoints 
with near perfect agreement (Kappa=0.832) and aligns with previous research regarding the 
recall reliability of age at menarche (Bergsten-Brucefors, 1976; Damon and Bajema, 1974; Holt 
et al., 1991; Must, 2002).  
 
Respondent answers for weight and height at menarche were highly unreliable between 
timepoints with significant differences reported across the 2 timepoints, suggesting the inability 
for respondents to remember exact information about body size at the time of menarche. The 
differences between some respondents’ answers would significantly skew the calculated BMI 
and thus could alter interpretation and relations of age at menarche, body composition and 
underlying energy availability. For example, a respondent that reported a height of 170.18 cm 
and weight of 55 kgs would have a calculated BMI of 19, which is considered normal. However, 
if they reported their weight within the 95% confidence interval range of error as 47 kgs, their 
calculated BMI would be 16.2, categorizing them as underweight. Since the specificities of the 
HPO axis and menstrual cycle in relation to energy availability was a significant point of interest 





This is contradictory to previous research which showed correlation between BMI percentile at 
menarche and recalled body size at menarche (Must, 2002), although a systematic bias was 
evident within this previous study. It is possible that girls at either end of the reporting extremes 
(low or high body weight or height) are less likely to accurately remember their stature compared 
to individuals in the ‘normative’ range for height and weight. Nonetheless, the lack of reliability 
regarding height and weight at menarche results in some hesitation moving forward regarding 
the accuracy of the information for our research question pertaining to BMI and age at menarche.  
 
The question of whether one’s menstrual cycle started occurring on a regular basis (every 21-35 
days) post second period (regularity) revealed moderate agreement. This aligns with previous 
research by Must (2002) which found that the recall of regularity of menstrual cycle to be poor, 
with the majority of errors in respondents classifying their cycles as irregular when they were 
not. While we have no medical records to judge respondent accuracy, reporting of irregular 
cycling (experiencing over 12 or under 10 menstrual cycles per year) within our data set was 
extremely high (over 40% within each age range section of the survey). Further analysis of 
menstrual cycle regularity will be discussed in section 5.5. 
 
Recall of the age for mother’s menarche showed substantial agreement (0.689), however, only 43 
(29.9%) respondents provided an answer to this question. This may indicate that when there is 
conversation between mother and daughter about getting their first period, this is a significant 
enough event to attain substantial retention for a daughter, but this conversation may not occur 
for all respondents. Of the 114 sisters that were reported within the survey, respondents answered 
on the age at menarche for 84.3% of them, with recall reliability ranging from substantial to fair-
moderate (Sister 1: 0.72, Substantial; Sister 2: 0.35, Fair; Sister 3: 0.40, Fair-moderate). Again, 
this could imply significant memory retention to events regarding menses for immediate family 
members. Although we did not ask about age gaps between sisters and the respondent, it is 
possible that sisters who are close in biological age and enter puberty and menarche in close 
temporal proximity, may remember these events more accurately than sisters who are further 





Recall of physical activity status (very active, somewhat active, or not active) at menarche 
proved to be highly reliable (near perfect agreement) between timepoints. While recall of 
physical activity has been studied widely with test-retest reliability as well as long-term recall 
validity (Blair, 1991; Brown, 2004; Falkner, 1999), our results are promising related to the recall 
reliability of physical activity status. This level of recall for physical activity status may be 
adequate for many research needs, but if the role of energy balance, menarche and athletic 
performance are of interest, this level of information is inadequate and does not provide the 
details necessary to fully elucidate the interplay between physical activity and onset of menarche.  
 
Indeed, when we asked more specific details related to menarche and physical activity, the 
reported number of hours of physical activity at menarche was only fairly reliable (fair 
agreement). This may be attributed to the difference in question presentation between T1 and 
T4mo. T1 provided a categorical selection of hours of physical activity (Not physically active; 
<5 hours; 5-10 hours; 11-15 hours; 16-20 hours; >20 hours; I cannot remember), while T4mo 
asked the open-ended question “How many hours per week were you physically active, on 
average?” allowing respondents to enter any value. These T4mo values were then categorized 
manually into the T1 boxes to calculate a kappa value. The kappa value here should be 
considered with some suspicion, since it is unclear if the lack of recall reliability is related to a 
difference in question presentation or truly poor recall.  
 
Instead, there could be merit to integrating an existing and validated physical activity survey into 
the HeRS. One such as the Kaiser Physical Activity Survey (KPAS) would encapsulate a broad 
range of physical activity habits (i.e., occupation, sports, active living habits, etc.) (Ainsworth, 
1999). While the International Physical Activity Questionnaire (IPAQ) would account for 
varying intensity levels of physical activity (Craig, 2003). 
 
Respondents’ recall of high weight, low weight, and height improved with age with post-college 
aged women having better recall reliability for height and high and low weight which would be 
expected given the fewer number of years between the time being recalled (Rubin and Baddeley, 




weight and height. The variability in responses regarding height seems especially alarming since 
height among most individuals should be relatively stable during the adult years (ages 25-40).  
 
Recall regarding the average number of cycles per year remained relatively stable and reliable 
throughout age ranges of the survey, resulting in a mediocre recall reliability of average 
menstrual cycles over a vast time span. This is contradictory with previous research which shows 
high reliability related to menstrual patterns (Kappa=0.68) (Bosetti, 2001) and cycle length 
(Bachand, 2009). Recall of whether one’s period stopped for more than two months significantly 
increased across the age ranges of the survey. This increased reliability could be explained by 
several factors. First, the older age groups may be more conscious about missed menstrual 
cycles, either due to greater regularity of menstruation compared to high school age years, 
greater consciousness given sexual activity and the chance of pregnancy or concentrated efforts 
to get pregnant (fertility issues).  
 
Meanwhile, highly variable responses were reported for the longest time without a menstrual 
cycle. This could be interpreted in a number of ways: individuals either missed their menstrual 
cycles often enough that they could not attribute a value with any significant reliability, or it was 
more an occasion to receive one’s menstrual cycle than miss it, so months of missing cycles were 
not being counted. In other words, in females with highly irregular menstrual cycles and 
longtime frames without cycles, where there was perhaps a performance benefit to having no 
cycle or missing it often, there would be little or no reason to take notice of missing cycles (or 
remember the numbers accurately). 
 
The impact of a change in physical activity on menstrual cycle characteristics (i.e. intensity, 
duration, and flow) revealed recall reliability kappa values showing only moderate level of 
agreement and suggests that most women likely don’t track menstrual cycle characteristics 
unless they have a medical or personal reason to do so.  
 
Finally, the use of birth control – as both the yes/no question of use during the time frame, as 
well as the categorical variable that asked for the specific form of birth control used – both 




birth control use across the lifetime, 2) the effort one must go to not only for obtaining birth 
control in the first place but keeping an active prescription (i.e., yearly gynecological exams, 
etc.), 3) the reasons behind using it, and 4) the side effects from using birth control—some of 
which are highly disruptive for some women. No other existing studies were found regarding the 
recall reliability of birth control use over significant timeframes as reflected in our current 
survey.  
 
While recall reliability of some questions was extremely high (i.e. age at menarche), others were 
extremely low (i.e. height and weight at menarche). It is possible that survey design (length and 
repetition of questions) and implementation potentially damaged recall validity between survey 
timepoints through survey fatigue. Asking respondents to take the survey twice within a 
relatively short time period (4 months) without telling them any results or findings of the 
previous survey could have caused respondents to believe that their input did not matter as much 
(Sinickas, 2007). Poor survey design (discussed within the previous section 5.1.1.) that included 
many repetitive questions and questions for which the respondents could not easily glean 
importance, may have also contributed to survey fatigue as respondents may have felt that a 
poorly constructed survey was not worth their utmost effort (Sinickas, 2007).  
 
 
5.3 Recall Reliability of Menarche Questions by Current Age 
 
Recall reliability of the menarche section of the HeRS grouped by current age revealed similar 
recall reliability of menarche and events surrounding that time period. This is counter to our 
hypothesis that older age groups would have less recall reliability than younger age groups.  
 
Specific to age at menarche, all current age groupings had either perfect agreement or near 
perfect agreement. Bergsten-Brucefors (1976) found that when recall of age at menarche was 
about four years since the time it occurred, the correlation between actual and reported age was 
0.81, and most errors (63%) were less than three months. Damon and Bajema (1974) found that 
when recall of age at menarche was 39 years away, the correlation was 0.61 with half (50%) of 




two studies align with the ideology of Holt et al. (1991) that there is a positive relation of 
magnitude of error and length of recall, analysis of the HeRS shows just as high of recall at the 
older age groups as the younger age groups, which is promising. However, it is important to note 
that in the current study, classification of age at menarche was within categorical groups (i.e. 
<11, 12-15, 16+) and respondents simply had to pick the same categorical group each time. 
While this categorical grouping of age at menarche may provide less specific data, it also is 
likely to significantly reduce the likelihood of error.  
 
These high values for recall reliability of age at menarche align with previous research 
suggesting that the retention of accurate memory relies most heavily on the subject matter being 
recalled (i.e. the saliency of the event), and less about the elapse of time between the recall and 
event (Cannell and Henson, 1974; Mathiowetz and Duncan, 1998). Given the shocking and 
oftentimes traumatic experience of one’s first menstrual cycle, and the high recall reliability 
rates, it seems reasonable to classify menarche as one such salient event. ` 
 
However, the ideal situation is to be able to check not just recall reliability but the accuracy of 
the responses against independent medical records (Dex, 1995), but that was not possible in the 
current study. Thus, it is possible that although older age groups do not appear to be less reliable 
between timepoints, their answers could be less accurate overall. This would align with Holt et 
al.’s (1991) study that found a positive relation between magnitude of error and length of recall 
regarding age at menarche.  
 
Other variables within the menarche section reveal further evidence that current age appears to 
play a minimal role in recall reliability between time points. Length of one’s first menstrual cycle 
(first_period_length) showed the oldest age group (35+) to have the highest agreement, while the 
two youngest age groups (18-24, 25-29) had moderate agreement. The question about the 
menstrual cycle becoming regular prior to their second cycle showed the youngest age group to 
have the highest agreement (closest proximity to event), followed by the middle (25-29) and 





Lastly, the question which asked whether respondents ever experienced any side effects from 
taking birth control showed relatively high agreement across all current age ranges. This may, 
once again, signify that pain or ill feelings caused from birth control are more salient experiences 
due to the conscious decision a woman must make in taking a hormonal supplement that can 
have serious impacts on one’s physiology and psychology, and thus, more reliable to recall well 
into older ages (Cannell and Henson, 1974; Mathiowetz and Duncan, 1998). However, this was 
also a yes/no categorical question, so while Cohen’s Kappa does account for the possibility of 




5.4 Physical Activity Level and BMI Relation to Age at Menarche 
 
While it is widely accepted that high energy expenditure may produce hormone deficiencies 
(Reed, 2018) and high-intensity training may delay the onset of menarche (Dusek, 2001), our 
results only mildly support this research. 
 
While our results showed that competitive athletes have the highest percentage of respondents 
that experienced primary amenorrhea (reached menarche after the age of 15) (10%; compared to 
2.9% of recreational athletes and 6.1 of non-athletes), the competitive athletes within this group 
did not report higher hours of physical activity participation than those who experienced 
menarche at younger ages. Our results show about half the competitive athletes reaching 
menarche below the age of 12 (early menarche) and had higher reported physical activity levels 
than those who experienced primary amenorrhea. The largest portion of respondents had a 
normative age at menarche (12-15; 109 respondents), which also contained the highest and 
lowest values of reported physical activity hours per week.  
 
Non-athletes also showed great variability in reported physical activity hours and age at 
menarche. Non-athletes had the highest percentage of respondents that experienced early 
menarche (11 or younger; 20.4%), but barely above recreational athletes (20%). On the other 




(6.1%), which could indicate high energy availability (possible obesity) associated with 
menstrual irregularities (Sharma, 2013; Talmor, 2015).  
 
Overall, our results pertaining to 144 respondents of the HeRS don’t match up with values from 
current literature. While 10% of competitive athletes in our study had primary amenorrhea and 
this aligns closely to Beals’ (2002) finding that 7.4% of 425 college athletes experienced primary 
amenorrhea, our overall percentage of respondents that experienced primary amenorrhea (6.9% 
overall, or 6.06% of the non-competitive athlete population) far exceeds the reported <1% of the 
general population (Chumlea, 2003).  
 
While the use of energy availability as a potential factor impacting age at menarche may seem 
unreliable given our lack of knowledge of caloric intake by individuals, further analysis of BMI 
confirms these wavering results. Corresponding to the research on energy availability and 
hormonal deficiencies, lower BMI and subcutaneous fat levels are often associated with later 
menarche (Lagowska & Kapczuk, 2016). However, our results are very indeterminate. In the 
competitive athlete category, those who experienced primary amenorrhea showed the same or 
higher BMIs than those who experienced normal or even early menarche. Recreational athletes 
showed the same average BMI no matter the age at menarche. Non-athletes were the only group 
which presented a distinct change in average BMI; those experiencing early menarche with the 
highest BMIs, normal menarche with medium BMIs, and primary amenorrhea with the lowest 
BMIs. This is the only group which aligns with the energy availability theory according to BMI.  
 
Our results must be viewed with caution, there are numerous issues with physical activity 
reporting and BMI that we have already addressed and the women self-selected designation as a 
recreational vs competitive athlete. In addition, we did not ask women to identify the types of 
sports they were competing in and thus, it is possible that our competitive athletes were all 
participating in sports where size (BMI) matters less (i.e., basketball, volleyball) or where being 
bigger is advantageous (i.e., rugby, football). Of additional consideration is that in the era of 
early specialization in a highly competitive sporting environment, being more mature at a 
younger age is actually advantageous. Thus, it is possible that the highly competitive sport 




capacity, more years for skill development at full adult height) in sports that do not require small 
size or aesthetics (i.e., gymnastics, figure skating, diving). Further research should be done on 
the HeRS regarding specific sport participation, as Beals (2002) reported an increase of primary 
amenorrhea to 22.2% of athletes within aesthetic sports. Also, greater analysis could be done on 
the intensity of physical activity, as those who reported high hours of physical activity may be 
doing so at a low intensity and vice versa, which may skew our perception of energy availability.  
 
 
5.5 Physical Activity Level by Number of Menstrual Cycles and Disordered Cycles 
 
Within our entire dataset, less than 60% of respondents reported having regularly occurring 
menstrual cycles (10-12 cycles per year) at each age range (HS: 56.9%; C: 58.3%; PC: 50%, 
n=108). This equates to over 40% of women at each age range experiencing some sort of 
irregular cycles that led them to experience more than 12 menstrual cycles or less than 10 cycles 
per year. The number of respondents that experienced less than 10 menstrual cycles per year 
(amenorrhea or oligomenorrhea) was 30.5% at the high school age, 36.1% at the college age, and 
34.7% at the post-college age. These numbers far exceed that of current research reporting 
amenorrhea and oligomenorrhea in the general population of 5% (Singh, 1981) or 1.8% 
(Peterson et al., 1973).  
 
Respondents that reported actual diagnosis of disordered menstrual cycles was less than the 
percentage of an irregular number of cycles, except at the post-college age (HS: 18.1%; C: 
27.1%; PC: 36.1%), but still much higher than current literature on the general population. These 
numbers regarding diagnosis likely differ from respondent reports of irregular cycles since the 
lack of menstruation is hardly a woman’s greatest burden and could even be viewed as 
beneficial, especially compared to the added burden of seeking medical attention.   
 
It should also be noted that within each age range, amenorrhea was the highest reported 
menstrual cycle disorder. This is contrary to common belief that a higher frequency of the 
population likely has oligomenorrhea (i.e., infrequent cycles, but still menstruating) than 




about the diagnosis or terminology used by medical professionals in the diagnosis of menstrual 
disorders. In addition, females with oligomenorrhea may be slipping through the cracks in the 
medical system and are rarely receiving follow-up or a diagnosis of any kind, unless their issues 
reach the level of amenorrhea.  
 
Due to the enormous amount of data in this study and some issues with poorly worded questions 
addressed earlier, we limited the next set of analysis to individuals that self-identified as 
competitive athletes only. Among these athletes, the percentage of respondents that reported 
regular cycling actually increased in the first 2 age groups. We could not look at the older age 
groups due to a low N. The percentage of these that experienced less than 10 menstrual cycles 
per year (amenorrhea or oligomenorrhea) was 29.6% at the high school age, 35.4% at the college 
age, and 46.2% at the post-college age. These values correspond to current literature reporting 
the prevalence of amenorrhea and oligomenorrhea in different athletic populations anywhere 
between 12% in cycling and swimming (Sanborn et al., 1982) to 79% in ballet (Abraham et al., 
1982).   
 
The average range of hours of physical activity performed by competitive athletes during the 
high school age was 10.6 +/- 3.54 (n=78), during the college age was 14.5 +/- 4.70 (n=48), and 
during the post-college age was 3.4 +/- 6.53 (n=13). Respondents reporting 0-3 menstrual cycles 
per year had the highest reported average physical activity hours per week (12.00 +/- 2.45). This 
aligns with current literature that lower energy availability from greater hours of physical activity 
may cause hormone deficiencies (Reed, 2008). In college, there was a small distinction between 
the average physical activity hours performed by those with regular cycles and those with 
irregular cycles, however, the relation was not linear and we did not control for the intensity of 
activity, so further analysis should be done on the sport being played and intensity performed 
(Dusek, 2001).  
 
While the percentage of competitive athletes that reported irregular cycles within this study is 
high, the percentage within the total population was even higher within some age ranges. When 
analyzing the frequency of menstrual cycle disorder diagnosis by self-identified athlete status 




be attributed to competitive athletes finding the lack of menstruation as a greater benefit to their 
sport than a concern for potential health consequences, especially given the lack of public 
knowledge regarding the existence of potential health consequences related to menstrual 
dysfunction. Additionally, this statistic may reflect that more menstrual irregularities are 
commonplace in the general population given the overweight/obesity epidemic (i.e., polycystic 
ovary syndrome) or it is also possible that more females are participating in recreational sports, 
restricting food intake and are actually less educated about these issues than competitive athletes. 
Thus, they may be more prone to menstrual irregularities. While low energy availability is often 
attributed to intense athletic participation, it is possible that other factors may be contributing to 
low energy availability within the general population (such as diet culture, recreational fitness, 
etc.) that is not being accounted for within current literature (Singh, 1981). It is also possible that 
participants of the HeRS that had experienced menstrual irregularities at some point felt more 
inclined to respond to both timepoints of the HeRS, and thus skewed our values.  
 
 
5.6 Change of Physical Activity Levels and Characteristics of the Menstrual Cycle 
 
During the high school age when the menstrual cycle is most irregular, nearly a third of all 
respondents (30.6%) had noticeable changes to their menstrual cycle characteristics (i.e., 
intensity, frequency, and duration) when they increased their physical activity level. This number 
decreased during the college age years (18-24: 12.5%), but then surprisingly increased again to 
29.6% during the post-college years (18.24; n=114). The number of respondents that reported 
noticeable changes to menstrual cycle characteristics attributed to a decrease in physical activity 
was much lower across all age ranges. Questions arise around the percentage of individuals that 
experienced a significant decrease in physical activity, as a significant decrease in PA may only 
be acknowledged due to a bad injury requiring significant recovery time or a long off season in 
which the individual got out of shape.  
 
Overall, an increase in physical activity led to the reporting of decreased menstrual cycle 
frequency (22.2%), intensity (7.6%), and duration (7.6%). Meanwhile a decrease in physical 




with our hypothesis, following the implications that higher physical activity means subsequently 
lower energy availability that correlates with less physiological energy reserved for the 
reproductive system, evident by a reduction in menstrual cycle frequency, duration, and intensity 
(Beals, 2002; Chumlea, 2003; Dusek, 2001; Freedman, 2002; Lagowska & Kapczuk, 2016; 
Mountjoy, 2018). While current literature most often acknowledges the impact of physical 
activity level on frequency of menstrual cycle (i.e., amenorrhea, oligomenorrhea), there is much 
less research on the impacts of physical activity on duration and flow of menstrual cycle which 
could also be indicators of anovulation (Talmor, 2015).  
 
 
5.7 Women Reporting the Use of Birth Control by Athletic Self-Identification 
 
Out of all 144 respondents which took the HeRS at both timepoints, 86.11% reported the use of 
some form of birth control during their lifetime.  
 
Results were largely mixed on whether athlete status – the self-reporting as a competitive athlete, 
recreational athlete, or non-athlete – played a role in the use of birth control. During the high 
school age years, recreational athletes were the highest subgroup reporting use of birth control, 
followed closely by non-athletes and then by competitive athletes. By the post-college age years, 
recreational athletes remained the largest group and had the highest percentage of birth control 
use (64%). The college age group had the highest percentages of birth control use across athlete 
type (comp=62.5%; rec=78.1%; non=78.1%). This would align with common literature that 
these years are often when women become increasingly sexually active (Martinez, 2015).  
 
While competitive athletes showed a similar increase in percentage use of birth control from high 
school age to college age (33.3% to 62.5%), the number of competitive athletes during this time 
frame decreased significantly (from n=78 to n=48), meaning that the number of individuals that 
reported the use of birth control only increased by 4 (26/78 to 30/48). If we assume that the 
reported competitive athletes in college were also competitive athletes in high school, then we 




school. The reason for this trend is unclear and further investigation should specifically address 
the reasons that competitive athletes use birth control.  
 
Across age ranges and athlete self-identification types, oral contraceptives were the most widely 
used form of birth control, followed by non-oral contraceptive. Multiple forms of birth control 
were reported most often during the college age years, mostly in recreational athletes, implying 
that this time period was when women most often explored birth control options to find one that 
most suited their needs.  
 
In summary, the HeRS has a range of recall reliabilities dependent on the questions of interest, 
with some questions having excellent recall reliability while others performed poorly. Further 
work with the HeRS should focus on removing repetitive questions that do not add significant 
information about reproductive history, clarifying wording of some questions to increase recall 
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SURVEY LABEL SURVEY QUESTION 





age18, hsage_check, age18_check Are you 18 years of age or older? 







At the time of your first period/ between the 
ages of 13-18/ between the ages of 18-24/ 








In what sport(s) were you a competitive 
athlete? (choice=Soccer, Basketball, Volleyball, 
Tennis, Swimming, Lacrosse, Softball, Golf, 




How many days per week did you train 
(include time playing the sport, lifting weights, 
and doing fitness)? 
hrswksport_tfp/hs/college/pc 
 
How many hours per week were you training 
for your sport (time spent playing on the field 
or in the gym, etc.)? 
hrswkextra_tfp/hs/college/pc 
 
How many hours per week were you doing 








How many days per week did you participate 
in high-intensity sport (running, weight lifting, 
HIIT training, etc.)? 
rechrshigh_tfp/hs/college/pc 
 




How many days per week did you participate 
in moderate-intensity sport (jogging, 
recreational sport, etc.)? 
rechrsmod_tfp/hs/college/pc 
 




How many days per week did you participate 




How many hours per day did you participate in 
low-intensity sport? 
Poor survey design 
(lack of specificity of 
the question and 
significant changes in 





Approximately how tall were you between the 
ages of 13 and 18? Please report in inches 
(exclude units).  If you do not remember, 




Poor survey design 









Between the ages of 13 and 18/ 18-24/ 25-40, 
did your menstrual cycle change due to your 




in affirmation to have 
recall reliability be of 
significance.  
hs/college/pc_ameno_age 
At what age were you diagnosed with 
amenorrhea? 
hs/college/pc _ameno_treat 
Please describe the type of treatment you 
received for amenorrhea between the ages of 
13 and 18/ 18-24/ 25-40. 
hs/college/pc _ameno_ongoing Is amenorrhea still an ongoing issue for you? 
hs/college/pc _amen_resolve 
When did your amenorrhea resolve? Please 
report the month and year in which it resolved 
to the best of your ability.  If you do not 
remember, please write I cannot remember. 
hs/college/pc _oligo_age 
At what age were you diagnosed with 
oligomenorrhea? 
hs/college/pc _oligo_treat 
Please describe the type of treatment you 
received for oligomenorrhea between the ages 
of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _oligo_ongoing 
Is oligomenorrhea still an ongoing issue for 
you? 
hs/college/pc _oligo_resolve 
When did your oligomenorrhea resolve? 
Please report the month and year in which it 
resolved to the best of your ability.  If you do 
not remember, please write I cannot 
remember. 
hs/college/pc _meno_age 
At what age were you diagnosed with 
menometrorrhagia? 
hs/college/pc _meno_treat 
Please describe the type of treatment you 
received for menometrorrhagia between the 
ages of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _meno_ongoing 
Is menometrorrhagia still an ongoing issue for 
you? 
hs/college/pc _meno_resolve 
When did your menometrorrhagia resolve? 
Please report the month and year in which it 
resolved to the best of your ability.  If you do 
not remember, please write I cannot 
remember. 
hs/college/pc _poly_age 
At what age were you diagnosed with 
polymenorrhea? 
hs/college/pc _poly_treat 
Please describe the type of treatment you 
received for polymenorrhea between the ages 
of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _poly_ongoing 
Is polymenorrhea still an ongoing issue for 
you? 
hs/college/pc _poly_resolve 
When did your polymenorrhea resolve? Please 
report the month and year in which it resolved 
to the best of your ability.  If you do not 
remember, please write I cannot remember. 
hs/college/pc _metro_age 
At what age were you diagnosed with 
metrorrhagia? 
hs/college/pc _metro_treat 
Please describe the type of treatment you 
received for metrorrhagia between the ages of 




hs/college/pc _metro_ongoing Is metrorrhagia still an ongoing issue for you? 
hs/college/pc _metro_resolve 
When did your metrorrhagia resolve? Please 
report the month and year in which it resolved 
to the best of your ability.  If you do not 
remember, please write I cannot remember. 
hs/college/pc _triad_age 
At what age were you diagnosed with the 
female athlete triad? 
hs/college/pc _triad_treat 
Please describe the type of treatment you 
received for the female athlete triad between 
the ages of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _triad_ongoing 
Is the female athlete triad still an ongoing issue 
for you? 
hs/college/pc _triad_resolve 
When did the female athlete triad resolve for 
you? Please report the month and year in 
which it resolved to the best of your ability.  If 
you do not remember, please write I cannot 
remember. 
hs/college/pc _reds_age At what age were you diagnosed with RED-S? 
hs/college/pc _reds_treat 
Please describe the type of treatment you 
received for RED-S between the ages of 13 and 
18/ 18-24/ 25-40. 
hs/college/pc _reds_ongoing Is the RED-S still an ongoing issue for you? 
hs/college/pc _reds_resolve 
When did RED-S resolve for you? Please report 
the month and year in which it resolved to the 
best of your ability.  If you do not remember, 
please write I cannot remember. 
hs/college/pc _anorexia_age 
At what age were you diagnosed with anorexia 
nervosa? 
hs/college/pc _anorexia_treat 
Please describe the type of treatment you 
received for anorexia nervosa between the 
ages of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _anorexia_ongoing 
Is anorexia nervosa still an ongoing issue for 
you? 
hs/college/pc _anorexia_resolve 
When did your anorexia nervosa resolve? 
Please report the month and year in which it 
resolved to the best of your ability.  If you do 
not remember, please write I cannot 
remember. 
hs/college/pc _bulimia_age 
At what age were you diagnosed with bulimia 
nervosa? 
hs/college/pc _bulimia_treat 
Please describe the type of treatment you 
received for bulimia nervosa between the ages 
of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _bulimia_ongoing 
Is bulimia nervosa still an ongoing issue for 
you? 
hs/college/pc _bulimia_resolve 
When did your bulimia nervosa resolve? Please 
report the month and year in which it resolved 
to the best of your ability.  If you do not 
remember, please write I cannot remember. 
hs/college/pc _binge_age 
At what age were you diagnosed with binge 
eating disorder? 
hs/college/pc _binge_treat 
Please describe the type of treatment you 
received for binge eating disorder between the 
ages of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _binge_ongoing 






When did your binge eating disorder resolve? 
Please report the month and year in which it 
resolved to the best of your ability.  If you do 
not remember, please write I cannot 
remember. 
hs/college/pc _purge_age 
At what age were you diagnosed with purging 
disorder? 
hs/college/pc _purge_treat 
Please describe the type of treatment you 
received for purging disorder between the 
ages of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _purge_ongoing 
Is purging disorder still an ongoing issue for 
you? 
hs/college/pc _purge_resolve 
When did your purging disorder resolve? 
Please report the month and year in which it 
resolved to the best of your ability.  If you do 
not remember, please write I cannot 
remember. 
hs/college/pc _avoidant_age 
At what age were you diagnosed with 
avoidant/restrictive food intake disorder? 
hs/college/pc _avoidant_treat 
Please describe the type of treatment you 
received for avoidant/restrictive food intake 
disorder between the ages of 13 and 18/ 18-
24/ 25-40. 
hs/college/pc _avoidant_ongoing 
Is avoidant/restrictive food intake disorder still 
an ongoing issue for you? 
hs/college/pc _avoidant_resolve 
When did your avoidant/restrictive food intake 
disorder resolve? Please report the month and 
year in which it resolved to the best of your 
ability.  If you do not remember, please write I 
cannot remember. 
hs/college/pc _night_age 
At what age were you diagnosed with night 
eating syndrome? 
hs/college/pc _night_treat 
Please describe the type of treatment you 
received for night eating syndrome between 
the ages of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _night_ongoing 
Is night eating syndrome still an ongoing issue 
for you? 
hs/college/pc _night_resolve 
When did your night eating syndrome resolve? 
Please report the month and year in which it 
resolved to the best of your ability.  If you do 
not remember, please write I cannot 
remember. 
hs/college/pc _pica_age At what age were you diagnosed with pica? 
hs/college/pc _pica_treat 
Please describe the type of treatment you 
received for pica between the ages of 13 and 
18/ 18-24/ 25-40. 
hs/college/pc _pica_ongoing Is pica still an ongoing issue for you? 
hs/college/pc _pica_resolve 
When did your pica resolve ? Please report the 
month and year in which it resolved to the best 
of your ability.  If you do not remember, please 
write I cannot remember. 
hs/college/pc _rumination_age 
At what age were you diagnosed with 
rumination syndrome? 
hs/college/pc _rumination_treat 
Please describe the type of treatment you 
received for rumination syndrome between 
the ages of 13 and 18/ 18-24/ 25-40. 
hs/college/pc _rumination_ongoing 






When did your rumination syndrome resolve? 
Please report the month and year in which it 
resolved to the best of your ability.  If you do 
not remember, please write I cannot 
remember. 
hs/college/pc _diabulimia_age 
At what age were you diagnosed with 
diabulimia? 
hs/college/pc _diabulimia_treat 
Please describe the type of treatment you 
received for diabulimia between the ages of 13 
and 18/ 18-24/ 25-40. 
h hs/college/pc _diabulimia_ongoing Is diabulimia still an ongoing issue for you? 
hs/college/pc _diabulimia_resolve 
When did your diabulimia resolve? Please 
report the month and year in which it resolved 
to the best of your ability.  If you do not 
remember, please write I cannot remember. 
To be analyzed in a 
future study 
hs_estro 
Please list the month/year you began taking an 
estrogen only pill, the dosage, and the 
month/year you stopped taking it. Please be as 
accurate as possible. If you do not remember, 





For what purpose(s) did you take an estrogen 
only pill between the ages of 13 and 18/ 18-
24/ 25-40? Choose all that apply.  
(choice=Avoidance of pregnancy, 
Control/regulate menstrual cycles, Initiate 
menstrual cycles, Pain, Control heavy bleeding, 
Avoid bleeding , Avoid cycles (prevent 
ovulation, Reduce injury risks, Reduce other 






For what purpose(s) did you take an progesterone 
only pill between the ages of 13 and 18/ 18-24/ 25-
40? Choose all that apply.  (choice=Avoidance of 
pregnancy, Control/regulate menstrual cycles, 
Initiate menstrual cycles, Pain, Control heavy 
bleeding, Avoid bleeding , Avoid cycles (prevent 
ovulation, Reduce injury risks, Reduce other 
symptoms (e.g. acne), Other, I do not know/I cannot 
remember) 
hs/college/pc_combo_purpose___1-10 
hs/college/pc _ combo _purpose___99 
hs/college/pc _ combo _purpose_other 
 
For what purpose(s) did you take an combined 
estrogen and progesterone pill between the ages of 
13 and 18/ 18-24/ 25-40? Choose all that apply.  
(choice=Avoidance of pregnancy, Control/regulate 
menstrual cycles, Initiate menstrual cycles, Pain, 
Control heavy bleeding, Avoid bleeding , Avoid cycles 
(prevent ovulation, Reduce injury risks, Reduce other 
symptoms (e.g. acne), Other, I do not know/I cannot 
remember) 
hs/college/pc_extended_purpose___1-10 
hs/college/pc _ extended _purpose___99 
hs/college/pc _ extended _purpose_other 
 
For what purpose(s) did you take an extended-cycle  
pill between the ages of 13 and 18/ 18-24/ 25-40? 
Choose all that apply.  (choice=Avoidance of 
pregnancy, Control/regulate menstrual cycles, 
Initiate menstrual cycles, Pain, Control heavy 
bleeding, Avoid bleeding , Avoid cycles (prevent 
ovulation, Reduce injury risks, Reduce other 
symptoms (e.g. acne), Other, I do not know/I cannot 
remember) 
hs/college/pc_vring_purpose___1-10 
hs/college/pc _ vring _purpose___99 
hs/college/pc _ vring _purpose_other 
 
For what purpose(s) did you take a vaginal ring 
between the ages of 13 and 18/ 18-24/ 25-40? 
Choose all that apply.  (choice=Avoidance of 




Initiate menstrual cycles, Pain, Control heavy 
bleeding, Avoid bleeding , Avoid cycles (prevent 
ovulation, Reduce injury risks, Reduce other 
symptoms (e.g. acne), Other, I do not know/I cannot 
remember) 
hs/college/pc_iud_purpose___1-10 
hs/college/pc _ iud _purpose___99 
hs/college/pc _ iud _purpose_other 
 
For what purpose(s) did you take an IUD between 
the ages of 13 and 18/ 18-24/ 25-40? Choose all that 
apply.  (choice=Avoidance of pregnancy, 
Control/regulate menstrual cycles, Initiate menstrual 
cycles, Pain, Control heavy bleeding, Avoid bleeding , 
Avoid cycles (prevent ovulation, Reduce injury risks, 
Reduce other symptoms (e.g. acne), Other, I do not 
know/I cannot remember) 
hs/college/pc_patch_purpose___1-10 
hs/college/pc _ patch _purpose___99 
hs/college/pc _ patch _purpose_other 
 
For what purpose(s) did you take an estrogen patch 
between the ages of 13 and 18/ 18-24/ 25-40? 
Choose all that apply.  (choice=Avoidance of 
pregnancy, Control/regulate menstrual cycles, 
Initiate menstrual cycles, Pain, Control heavy 
bleeding, Avoid bleeding , Avoid cycles (prevent 
ovulation, Reduce injury risks, Reduce other 
symptoms (e.g. acne), Other, I do not know/I cannot 
remember) 
hs/college/pc_implant_purpose___1-10 
hs/college/pc _ implant _purpose___99 
hs/college/pc _ implant _purpose_other 
 
For what purpose(s) did you take an implant 
between the ages of 13 and 18/ 18-24/ 25-40? 
Choose all that apply.  (choice=Avoidance of 
pregnancy, Control/regulate menstrual cycles, 
Initiate menstrual cycles, Pain, Control heavy 
bleeding, Avoid bleeding , Avoid cycles (prevent 
ovulation, Reduce injury risks, Reduce other 
symptoms (e.g. acne), Other, I do not know/I cannot 
remember) 
hs/college/pc_other_purpose___1-10 
hs/college/pc _ other _purpose___99 
hs/college/pc_other _purpose_other 
 
For what purpose(s) did you use the other form(s) of 
birth control  between the ages of 13 and 18/ 18-24/ 
25-40? Choose all that apply.  (choice=Avoidance of 
pregnancy, Control/regulate menstrual cycles, 
Initiate menstrual cycles, Pain, Control heavy 
bleeding, Avoid bleeding , Avoid cycles (prevent 
ovulation, Reduce injury risks, Reduce other 
symptoms (e.g. acne), Other, I do not know/I cannot 
remember) 
hs/college/pc _pregnancy 
Between the ages of 13 and 18/ 18-24/ 25-40 were 
you ever pregnant? 
hs/college/pc _preg_number 
How many times did you become pregnant between 
the ages of 13 and 18/ 18-24/ 25-40? 
hs/college/pc _preg_years 
Please list each pregnancy that occurred between 
the ages of 13 and 18/ 18-24/ 25-40 by the year in 
which you became pregnant (e.g. Pregnancy 1 
(1985)). 
hs/college/pc _preg1-5 First-fifth Pregnancy 
hs/college/pc _1-5preg_type 
Was the first-fifth pregnancy between the ages of 13 
and 18 / 18-24/ 25-40 naturally occurring or though 
IVF? 
hs/college/pc _1-5preg_term 
Was your first-fifth pregnancy between the ages of 





































































































































































































































































 COLLEGE HIGH WEIGHT 
 
 














COLLEGE PERIOD NUMBER 
 
 
COLLEGE PERIOD STOP (yes/no) 
 
 







COLLEGE PERIOD STOP LENGTH 
 
 


















































COLLEGE MISSED TRAINING DUE TO MENSTRUAL CYCLE (yes/no) 
 
 
COLLEGE MISSED TRAINING categorized (cycle symptoms) 
 
 







COLLEGE HIGH PERFORMANCE values (times during cycle) 
 
 
COLLEGE LOW PERFORMANCE DURING CYCLE? (yes/no) 
 
 






COLLEGE MEDICAL CONDITION 
 
 
COLLEGE BIRTH CONTROL (yes/no) 
 
 






POST-COLLEGE HIGH WEIGHT 
 
 




























POST-COLLEGE PERIOD STOP LENGTH 
 
 


















































POST-COLLEGE MISSED TRAINING DUE TO MENSTRUAL CYCLE (yes/no) 
 
 




































































APPENDIX E. RECALL RELIABILITY OF MENARCHE BE CURRENT AGE  



















































































































































 AGE AT FIRST PERIOD BY SELF-IDENTIFIED ATHLETE TYPE 
 
   
FREQUENCY OF RESPONDENTS BY AGE AT MENARCHE 
 
 
AVERAGE PHYSICAL ACTIVITY HOURS BY SELF-IDENTIFIED ATHLETE TYPE 
 
 









































































COMPETITIVE ATHLETE PA LEVEL POST-COLLEGE BY AVG ANNUAL PERIOD 
NUMBER 
 
 
 
 
 
